☰

Jason S. Lewis - Publications

Affiliations: 
Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States 
Tree Info Similar researchers PubMed Report error

319/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Mack KN, Samuels ZV, Carter LM, Viray TD, Mandleywala K, Brooks CL, Hollingsworth MA, Radhakrishnan P, Lewis JS. Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38485271 DOI: 10.2967/jnumed.123.266524  0.355
2023 Surendra Panikar S, Shmuel S, Lewis JS, Pereira PMR. PET and Optical Imaging of Caveolin-1 in Gastric Tumors. Acs Omega. 8: 35884-35892. PMID 37810678 DOI: 10.1021/acsomega.3c03614  0.315
2023 Bauer D, Cornejo MA, Hoang TT, Lewis JS, Zeglis BM. Click Chemistry and Radiochemistry: An Update. Bioconjugate Chemistry. PMID 37737084 DOI: 10.1021/acs.bioconjchem.3c00286  0.545
2023 Hernández-Gil J, Chow CY, Chatras H, de Souza França PD, Samuels ZV, Cornejo M, King GF, Lewis JS, Reiner T, Gonzales J. Development and Validation of Nerve-Targeted Bacteriochlorin Sensors. Journal of the American Chemical Society. 145: 14276-14287. PMID 37339504 DOI: 10.1021/jacs.3c02520  0.554
2023 Bauer D, Sarrett SM, Lewis JS, Zeglis BM. Click chemistry: a transformative technology in nuclear medicine. Nature Protocols. PMID 37100960 DOI: 10.1038/s41596-023-00825-8  0.533
2022 Zeglis BM, Lewis JS. Click Here for Better Chemistry. The New England Journal of Medicine. PMID 36449446 DOI: 10.1056/NEJMcibr2213596  0.524
2022 Dos Santos JC, Schäfer M, Bauder-Wüst U, Beijer B, Eder M, Leotta K, Kleist C, Meyer JP, Dilling TR, Lewis JS, Kratochwil C, Kopka K, Haberkorn U, Mier W. Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617. Frontiers in Chemistry. 10: 898692. PMID 36017165 DOI: 10.3389/fchem.2022.898692  0.728
2022 Bauer D, Visca H, Weerakkody A, Carter LM, Samuels Z, Kaminsky S, Andreev OA, Reshetnyak YK, Lewis JS. PET Imaging of Acidic Tumor Environment With Zr-labeled pHLIP Probes. Frontiers in Oncology. 12: 882541. PMID 35664740 DOI: 10.3389/fonc.2022.882541  0.318
2022 Maitz CA, Delaney S, Cook BE, Genady AR, Hoerres R, Kuchuk M, Makris G, Valliant JF, Sadeghi S, Lewis JS, Hennkens HM, Bryan JN, Zeglis BM. Pretargeted PET of Osteodestructive Lesions in Dogs. Molecular Pharmaceutics. PMID 35635337 DOI: 10.1021/acs.molpharmaceut.2c00220  0.593
2022 Hoang TT, Mandleywala K, Viray T, Tan KV, Lewis JS, Pereira PMR. EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors. Molecular Imaging and Biology. PMID 35147837 DOI: 10.1007/s11307-022-01708-2  0.313
2022 Nagle VL, Hertz CAJ, Henry KE, Graham MS, Campos C, Pillarsetty N, Schietinger A, Mellinghoff IK, Lewis JS. Non-invasive imaging of CD4+ T cells in humanized mice. Molecular Cancer Therapeutics. PMID 35131877 DOI: 10.1158/1535-7163.MCT-21-0888  0.723
2021 Sharma SK, Mack KN, Piersigilli A, Pourat J, Edwards KJ, Keinänen O, Jiao MS, Zhao H, White B, Brooks CL, de Stanchina E, Madiyalakan R, Hollingsworth MA, Radhakrishnan P, Lewis JS, et al. ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34907079 DOI: 10.1158/1078-0432.CCR-21-1798  0.802
2021 Nie P, Kalidindi T, Nagle VL, Wu X, Li T, Liao GP, Frost G, Henry KE, Punzalan B, Carter LM, Lewis JS, Pillarsetty NVK, Li YM. Imaging of Cancer γ-Secretase Activity Using an Inhibitor-based PET Probe. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34475100 DOI: 10.1158/1078-0432.CCR-21-0940  0.774
2021 Henry KE, Mack KN, Nagle VL, Cornejo M, Michel AO, Fox IL, Davydova M, Dilling TR, Pillarsetty N, Lewis JS. ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. PMID 34349003 DOI: 10.1158/1535-7163.MCT-20-1112  0.76
2021 Pillarsetty N, Carter L, Lewis JS, Reiner T. REPLY TO LETTER TO THE EDITOR: POTENTIAL USE OF RADIOLABELED ANTIBODIES FOR IMAGING AND TREATMENT OF COVID-19. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33893187 DOI: 10.2967/jnumed.121.261950  0.529
2021 Sharma SK, Adumeau P, Keinänen O, Sisodiya V, Sarvaiya H, Tchelepi R, Korsen JA, Pourat J, Edwards KJ, Ragupathi A, Hamdy O, Saunders LR, Rudin CM, Poirier JT, Lewis JS, et al. Synthesis and Comparative Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET. Bioconjugate Chemistry. PMID 33835770 DOI: 10.1021/acs.bioconjchem.1c00121  0.811
2021 Henry KE, Shaffer T, Mack KN, Ring J, Ogirala A, Klein-Scory S, Eilert-Micus C, Schmiegel W, Bracht T, Sitek B, Clyne M, Reid C, Sipos B, Lewis JS, Kalthoff H, et al. Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33712530 DOI: 10.2967/jnumed.120.256776  0.73
2021 Nagle VL, Henry KE, Hertz CAJ, Graham MS, Campos C, Parada LF, Pandit-Taskar N, Schietinger A, Mellinghoff IK, Lewis JS. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [Cu]Cu-NOTA-anti-CD8-Positron Emission Tomography. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33495310 DOI: 10.1158/1078-0432.CCR-20-3243  0.751
2021 Gonzales J, Hernández-Gil J, Wilson TC, Adilbay D, Cornejo M, Demétrio de Souza Franca P, Guru N, Schroeder CI, King GF, Lewis JS, Reiner T. Bimodal Imaging of Mouse Peripheral Nerves with Chlorin Tracers. Molecular Pharmaceutics. PMID 33404254 DOI: 10.1021/acs.molpharmaceut.0c00946  0.516
2020 Pandya DN, Henry KE, Day CS, Graves SA, Nagle VL, Dilling TR, Sinha A, Ehrmann BM, Bhatt NB, Menda Y, Lewis JS, Wadas TJ. Polyazamacrocycle Ligands Facilitate Zr Radiochemistry and Yield Zr Complexes with Remarkable Stability. Inorganic Chemistry. PMID 33169605 DOI: 10.1021/acs.inorgchem.0c02722  0.791
2020 Mason CA, Carter LM, Mandleywala K, de Souza Franca PD, Meyer JP, Mamun T, Backer JM, Backer MV, Reiner T, Lewis JS. Imaging Early-Stage Metastases Using an F-Labeled VEGFR-1-Specific Single Chain VEGF Mutant. Molecular Imaging and Biology. PMID 33156495 DOI: 10.1007/s11307-020-01555-z  0.554
2020 Keinänen O, Fung K, Brennan JM, Zia N, Harris M, van Dam E, Biggin C, Hedt A, Stoner J, Donnelly PS, Lewis JS, Zeglis BM. Harnessing Cu/Cu for a theranostic approach to pretargeted radioimmunotherapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 33106429 DOI: 10.1073/pnas.2009960117  0.782
2020 Mandleywala K, Shmuel S, Pereira PMR, Lewis JS. Antibody-Targeted Imaging of Gastric Cancer. Molecules (Basel, Switzerland). 25. PMID 33050602 DOI: 10.3390/molecules25204621  0.348
2020 Brito A, Pereira PMR, Reis RL, Ulijn RV, Lewis JS, Pires RA, Pashkuleva I. Aromatic carbohydrate amphiphile disrupts cancer spheroids and prevents relapse. Nanoscale. 12: 19088-19092. PMID 32955076 DOI: 10.1039/D0Nr05008C  0.311
2020 Hernández-Gil J, Lewis JS, Reiner T, Drain CM, Gonzales J. Leveraging synthetic chlorins for bio-imaging applications. Chemical Communications (Cambridge, England). PMID 32945820 DOI: 10.1039/D0Cc05494A  0.6
2020 Sobol NB, Korsen JA, Younes A, Edwards KJ, Lewis JS. ImmunoPET Imaging of Pancreatic Tumors with Zr-Labeled Gold Nanoparticle-Antibody Conjugates. Molecular Imaging and Biology. PMID 32909244 DOI: 10.1007/S11307-020-01535-3  0.363
2020 Sarbisheh EK, Salih AK, Raheem SJ, Lewis JS, Price EW. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89. Inorganic Chemistry. 59: 11715-11727. PMID 32799484 DOI: 10.1021/Acs.Inorgchem.0C01629  0.314
2020 Pillarsetty N, Carter L, Lewis JS, Reiner T. Oncology-inspired treatment options for COVID-19. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32680924 DOI: 10.2967/Jnumed.120.249748  0.542
2020 Ulaner GA, Jhaveri K, Chardarlapaty S, Hatzoglou V, Riedl C, Lewis JS, Mauguen A. Head-to-head evaluation of F-FES and F-FDG PET/CT in metastatic invasive lobular breast cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32680923 DOI: 10.2967/Jnumed.120.247882  0.333
2020 Pereira PMR, Norfleet J, Lewis JS, Escorcia FE. ImmunoPET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32646879 DOI: 10.2967/Jnumed.120.244897  0.342
2020 Fung K, Sharma SK, Keinänen O, Long Roche K, Lewis JS, Zeglis BM. A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High Grade Serous Ovarian Cancer. Molecular Pharmaceutics. PMID 32644804 DOI: 10.1021/Acs.Molpharmaceut.0C00437  0.808
2020 Ulaner GA, Carrasquillo JA, Riedl CC, Yeh R, Hatzoglou V, Ross DS, Jhaveri K, Chandarlapaty S, Hyman DM, Zeglis BM, Lyashchenko SK, Lewis JS. Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted Zr-Pertuzumab PET/CT. Radiology. 192828. PMID 32515679 DOI: 10.1148/Radiol.2020192828  0.641
2020 Poty S, Mandleywala K, O'Neill E, Knight JC, Cornelissen B, Lewis JS. Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma. Theranostics. 10: 5802-5814. PMID 32483420 DOI: 10.7150/Thno.44772  0.415
2020 Gonzales J, Pirovano G, Chow CY, de Souza Franca PD, Carter LM, Klint JK, Guru N, Lewis JS, King GF, Reiner T. Fluorescence labeling of a Na1.7-targeted peptide for near-infrared nerve visualization. Ejnmmi Research. 10: 49. PMID 32409881 DOI: 10.1186/S13550-020-00630-4  0.518
2020 Nemieboka B, Sharma SK, Rao TD, Edwards KJ, Yan S, Wang P, Ragupathi A, Piersigilli A, Spriggs DR, Lewis JS. Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation. Nuclear Medicine and Biology. 86: 9-19. PMID 32403071 DOI: 10.1016/J.Nucmedbio.2020.04.006  0.365
2020 Krebs S, O'Donoghue JA, Biegel E, Beattie BJ, Reidy D, Lyashchenko SK, Lewis JS, Bodei L, Weber WA, Pandit-Taskar N. Comparison of Ga-DOTA-JR11 PET/CT with dosimetric Lu-satoreotide tetraxetan (Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32378020 DOI: 10.1007/S00259-020-04832-9  0.37
2020 Dunphy MP, Pressl C, Pillarsetty N, Grkovski M, Modi S, Jhaveri K, Norton L, Beattie BJ, Zanzonico PB, Zatorska D, Taldone T, Ochiana SO, Uddin MM, Burnazi EM, Lyashchenko SK, ... ... Lewis JS, et al. First-in-Human Trial of Epichaperome-Targeted Positron Emission Tomography in Cancer Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32366671 DOI: 10.1158/1078-0432.Ccr-19-3704  0.435
2020 Carter LM, Henry KE, Platzman A, Lewis JS. 3D-Printable Platform for High-Throughput Small-Animal Imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32284395 DOI: 10.2967/Jnumed.119.240457  0.734
2020 Ulaner GA, Sobol NB, O'Donoghue JA, Kirov AS, Riedl CC, Min R, Smith E, Carter LM, Lyashchenko SK, Lewis JS, Landgren CO. CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging. Radiology. 192621. PMID 32255416 DOI: 10.1148/Radiol.2020192621  0.405
2020 Goos JACM, Davydova M, Lengkeek N, Greguric I, Whittaker MR, Quinn JF, Baell JB, Lewis JS, Davis TP. pH-Responsive Polymers for Improving the Signal-to-Noise Ratio of Hypoxia PET Imaging with [ F]Fluoromisonidazole. Macromolecular Rapid Communications. e2000061. PMID 32250004 DOI: 10.1002/Marc.202000061  0.344
2020 Schöder HM, Demétrio De Souza França P, Nakajima R, Burnazi EM, Roberts S, Brand C, Grkovski M, Mauguen A, Dunphy MP, Ghossein R, Lyashchenko SK, Lewis JS, O'Donoghue JA, Ganly I, Patel SG, et al. Safety and feasibility of PARP1/2 imaging with 18F-PARPi in patients with head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32245901 DOI: 10.1158/1078-0432.Ccr-19-3484  0.59
2020 Li BT, Michelini F, Misale S, Cocco E, Baldino L, Cai Y, Shifman S, Tu HY, Myers ML, Xu C, Mattar M, Khodos I, Little M, Qeriqi B, Weitsman G, ... ... Lewis JS, et al. HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers. Cancer Discovery. PMID 32213539 DOI: 10.1158/2159-8290.Cd-20-0215  0.324
2020 Sharma SK, Glaser JM, Edwards KJ, Khozeimeh Sarbisheh E, Salih AK, Lewis JS, Price EW. A Systematic Evaluation of Antibody Modification and 89Zr-Radiolabeling for Optimized Immuno-PET. Bioconjugate Chemistry. PMID 32197571 DOI: 10.1021/Acs.Bioconjchem.0C00087  0.365
2020 Krebs S, Veach DR, Carter LM, Grkovski M, Fornier M, Mauro MJ, Voss MH, Danila DC, Burnazi E, Null M, Staton K, Pressl C, Beattie BJ, Zanzonico PB, Weber WA, ... ... Lewis JS, et al. First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32169913 DOI: 10.2967/Jnumed.119.234864  0.393
2020 Goos JACM, Davydova M, Dilling TR, Cho A, Cornejo MA, Gupta A, Price WS, Puttick S, Whittaker MR, Quinn JF, Davis TP, Lewis JS. Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue. Nuclear Medicine and Biology. 84: 63-72. PMID 32135473 DOI: 10.1016/J.Nucmedbio.2020.02.012  0.763
2020 Imberti C, Adumeau P, Blower JE, Al Salemee F, Baguña Torres J, Lewis JS, Zeglis BM, Terry SYA, Blower PJ. Manipulating the In Vivo Behaviour of Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood Clearance. International Journal of Molecular Sciences. 21. PMID 32098299 DOI: 10.3390/Ijms21041496  0.608
2020 Pereira PMR, Edwards KJ, Mandleywala K, Carter LM, Escorcia FE, Campesato LF, Cornejo M, Abma L, Mohsen AA, Iacobuzio-Donahue CA, Merghoub T, Lewis JS. iNOS regulates the therapeutic response of pancreatic cancer cells to radiation therapy. Cancer Research. PMID 32086240 DOI: 10.1158/0008-5472.Can-19-2991  0.329
2020 Pirovano G, Jannetti SA, Carter LM, Sadique A, Kossatz S, Guru N, Demétrio De Souza França P, Maeda M, Zeglis BM, Lewis JS, Humm JL, Reiner T. Targeted brain tumor radiotherapy using an Auger emitter. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32066626 DOI: 10.1158/1078-0432.Ccr-19-2440  0.706
2020 Vivier D, Fung K, Rodriguez C, Adumeau P, Ulaner GA, Lewis JS, Sharma SK, Zeglis BM. The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and Performance of Zr-DFO-Pertuzumab. Theranostics. 10: 1746-1757. PMID 32042334 DOI: 10.7150/Thno.39089  0.63
2020 Pereira PMR, Roberts S, Figueira F, Tome JPC, Reiner T, Lewis JS. PET/CT imaging with a F-labeled galactodendritic unit in a galectin-1 overexpressing orthotopic bladder cancer model. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32005776 DOI: 10.2967/Jnumed.119.236430  0.624
2020 Henry KE, Chaney AM, Nagle VL, Cropper HC, Mozaffari S, Slaybaugh G, Parang K, Andreev O, Reshetnyak YK, James ML, Lewis JS. Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH-Low Insertion Cyclic (pHLIC) Peptide. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32005774 DOI: 10.2967/Jnumed.119.233072  0.742
2020 Goos JACM, Cho A, Carter LM, Dilling TR, Davydova M, Mandleywala K, Puttick S, Gupta A, Price WS, Quinn JF, Whittaker MR, Lewis JS, Davis TP. Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect. Theranostics. 10: 567-584. PMID 31903138 DOI: 10.7150/Thno.36777  0.761
2020 Escorcia FE, Houghton JL, Abdel-Atti D, Pereira PR, Cho A, Gutsche NT, Baidoo KE, Lewis JS. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors. Theranostics. 10: 151-165. PMID 31903112 DOI: 10.7150/Thno.37098  0.595
2019 Pereira PMR, Ragupathi A, Shmuel S, Mandleywala K, Viola NT, Lewis JS. HER2-targeted PET imaging and therapy of hyaluronan-masked HER2-overexpressing breast cancer. Molecular Pharmaceutics. PMID 31804840 DOI: 10.1021/Acs.Molpharmaceut.9B01091  0.395
2019 Lewis JS, Membreno R. Correction to: The 2019 World Molecular Imaging Congress (WMIC) and Molecular Imaging and Biology (MIB) Awards. Molecular Imaging and Biology. PMID 31802360 DOI: 10.1007/S11307-019-01457-9  0.317
2019 Lewis JS. Changing of the Guard at Molecular Imaging & Biology. Molecular Imaging and Biology. PMID 31792840 DOI: 10.1007/S11307-019-01446-Y  0.303
2019 Sarparanta M, Pourat J, Carnazza KE, Tang J, Paknejad N, Reiner T, Kostiainen MA, Lewis JS. Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer. Nuclear Medicine and Biology. 80: 1-12. PMID 31759312 DOI: 10.1016/J.Nucmedbio.2019.11.002  0.775
2019 Lewis JS, Membreno R. The 2019 World Molecular Imaging Congress (WMIC) and Molecular Imaging and Biology (MIB) Awards. Molecular Imaging and Biology. PMID 31667716 DOI: 10.1007/S11307-019-01444-0  0.32
2019 Pandit-Taskar N, Postow M, Hellmann M, Harding J, Barker C, O'Donoghue J, Ziolkowska M, Ruan S, Lyashchenko S, Tsai F, Farwell M, Mitchell T, Korn R, Le W, Lewis J, et al. First-in-human imaging with Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31586002 DOI: 10.2967/Jnumed.119.229781  0.365
2019 Lohrmann C, O'Reilly EM, O'Donoghue JA, Pandit-Taskar N, Carrasquillo JA, Lyashchenko SK, Ruan S, Teng R, Scholz WW, Maffuid PW, Lewis JS, Weber WA. Retooling a Blood-based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31540979 DOI: 10.1158/1078-0432.Ccr-18-3667  0.375
2019 Mason C, Kossatz S, Carter L, Pirovano G, Brand C, Guru N, Pérez-Medina C, Lewis JS, Mulder W, Reiner T. A Zr-HDL PET tracer monitors response to a CSF1R inhibitor. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31420495 DOI: 10.2967/Jnumed.119.230466  0.611
2019 Pandit-Taskar N, Zanzonico PB, Kramer K, Grkovski M, Fung EK, Shi W, Zhang Z, Lyashchenko SK, Vietri SM, Fung AM, Pentlow KS, Carrasquillo JA, Lewis JS, Larson SM, Cheung NV, et al. Biodistribution and Dosimetry of Intraventricularly Administered I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31405921 DOI: 10.2967/Jnumed.118.219576  0.337
2019 Bhupathiraju NVSDK, Younes A, Cao M, Ali J, Cicek HT, Tully KM, Ponnala S, Babich JW, Deri MA, Lewis JS, Francesconi LC, Drain CM. Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO. Organic & Biomolecular Chemistry. PMID 31268109 DOI: 10.1039/C9Ob01068H  0.401
2019 Roberts S, Strome A, Choi C, Andreou C, Kossatz S, Brand C, Williams T, Bradbury M, Kircher MF, Reshetnyak YK, Grimm J, Lewis JS, Reiner T. Acid specific dark quencher QC1 pHLIP for multi-spectral optoacoustic diagnoses of breast cancer. Scientific Reports. 9: 8550. PMID 31189972 DOI: 10.1038/S41598-019-44873-1  0.582
2019 Pereira PM, Mandleywala K, Ragupathi A, Carter LM, Goos JACM, Janjigian YY, Lewis JS. Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31171598 DOI: 10.2967/Jnumed.119.225813  0.413
2019 Lobatto ME, Binderup T, Robson PM, Giesen LFP, Calcagno C, Witjes J, Fay F, Baxter S, Wessel CH, Eldib M, Bini J, Carlin SD, Stroes ESG, Storm G, Kjær A, ... Lewis JS, et al. Multimodal positron emission tomography imaging to quantify uptake of 89Zr-labeled liposomes in the atherosclerotic vessel wall. Bioconjugate Chemistry. PMID 31095372 DOI: 10.1021/Acs.Bioconjchem.9B00256  0.601
2019 Carter LM, Kesner AL, Pratt EC, Sanders VA, Massicano AVF, Cutler CS, Lapi SE, Lewis JS. The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional Radionuclides. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 31001765 DOI: 10.1007/S11307-019-01337-2  0.368
2019 Membreno R, Keinänen OM, Cook BE, Tully KM, Fung KC, Lewis JS, Zeglis BM. Towards the Optimization of Click-Mediated Pretargeted Radioimmunotherapy. Molecular Pharmaceutics. PMID 30912951 DOI: 10.1021/Acs.Molpharmaceut.9B00062  0.795
2019 Kramer GM, Yaqub M, Vargas HA, Schuit R, Windhorst AD, van den Eertwegh A, van der Veldt A, Bergman A, Burnazi E, Lewis JS, Chua SS, Staton K, Beattie BJ, Humm JL, Davis ID, et al. Assessment of simplified methods for quantification of F-FDHT uptake in patients with metastatic castration-resistant prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30850488 DOI: 10.2967/Jnumed.118.220111  0.33
2019 Curado N, Dewaele-Le Roi G, Poty S, Lewis JS, Contel M. Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines. Chemical Communications (Cambridge, England). PMID 30632546 DOI: 10.1039/C8Cc08769E  0.314
2019 Cutler CS, Lewis JS, Anderson CJ. Utilization of metabolic, transport and receptor-mediated processes to deliver agents for cancer diagnosis. Advanced Drug Delivery Reviews. 37: 189-211. PMID 10837735 DOI: 10.1016/S0169-409X(98)00093-3  0.376
2019 Jhaveri K, Dunphy M, Wang R, Comen E, Fornier M, Moynahan M, Bromberg J, Ma W, Patil S, Taldone T, Rodina A, Sterlin V, Khoshi S, Lewis J, Norton L, et al. Abstract P6-20-03: Tumor epichaperome expression using 124I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC) Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P6-20-03  0.383
2019 Lewis JS. Abstract I18: Retooling a blood-based biomarker into a theranostic agent Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-I18  0.461
2019 Crawford T, Moshnikova A, Roles S, Carter LM, Lewis JS, Engelman DM, Andreev OA, Reshetnyak YK. Abstract 1956: ICG pHLIP: A novel agent for fluorescence-guided surgery Cancer Research. 79: 1956-1956. DOI: 10.1158/1538-7445.Am2019-1956  0.418
2019 Walsh J, Francesconi L, Sanders V, Iskhakov D, Zeglis B, Lewis J. Improving excretory pathways of technetium-99m SPECT imaging agents based on bioorthogonal Diels-Alder click chemistry Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30366-X  0.611
2019 Tully K, Demoin D, Deri M, Hatcher J, Francesconi L, Lewis J. Evaluating HOPO chelators with therapeutic radioisotopes for theranostic applications in immunoPET imaging and radioimmunotherapy Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30324-5  0.352
2019 Membreno R, Cook B, Tully K, Lewis J, Zeglis B. The optimization of click-mediated pretargeted radioimmunotherapy Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30237-9  0.546
2019 Poty S, Knight J, Mandleywala K, Membreno R, Abdel-Atti D, Scholz W, Zeglis B, Cornelissen B, Lewis J. Pretargeted 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma: evaluating DNA-damage with 89Zr-PET Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30231-8  0.588
2019 Henry K, Pandya D, Nikunj B, Nagle V, Dilling T, Wadas T, Lewis J. Teaching old ligands new tricks: macrocyclic chelators for zirconium-89 radiochemistry Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30229-X  0.699
2019 Poty S, Knight JC, Donabedian P, Mandleywala K, Cornelissen B, Reiner T, Lewis JS. PET Imaging of DNA Damage Response following 225Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model Journal of Medical Imaging and Radiation Sciences. 50: S4-S5. DOI: 10.1016/J.Jmir.2019.03.014  0.571
2019 Ulaner G, Sobol N, O'Donoghue J, Lyashchenko S, Lewis J, Landgren CO. Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma Clinical Lymphoma Myeloma and Leukemia. 19: e19. DOI: 10.1016/J.Clml.2019.09.027  0.333
2018 Pereira PMR, Sharma SK, Carter LM, Edwards KJ, Pourat J, Ragupathi A, Janjigian YY, Durack JC, Lewis JS. Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy. Nature Communications. 9: 5137. PMID 30510281 DOI: 10.1038/S41467-018-07608-W  0.311
2018 Sanchez-Vega F, Hechtman JF, Castel P, Ku GY, Tuvy Y, Won H, Fong CJ, Bouvier N, Nanjangud GJ, Soong J, Vakiani E, Schattner M, Kelsen DP, Lefkowitz RA, Brown K, ... ... Lewis JS, et al. EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer. Cancer Discovery. PMID 30463996 DOI: 10.1158/2159-8290.Cd-18-0598  0.343
2018 Krebs S, Pandit-Taskar N, Reidy D, Beattie BJ, Lyashchenko SK, Lewis JS, Bodei L, Weber WA, O'Donoghue JA. Biodistribution and radiation dose estimates for Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30374529 DOI: 10.1007/S00259-018-4193-Y  0.378
2018 Poty S, Carter LM, Mandleywala K, Membreno R, Abdel-Atti D, Ragupathi A, Scholz WW, Zeglis BM, Lewis JS. Leveraging bioorthogonal click chemistry to improve 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30352909 DOI: 10.1158/1078-0432.Ccr-18-1650  0.614
2018 Senders ML, Hernot S, Carlucci G, van de Voort JC, Fay F, Calcagno C, Tang J, Alaarg A, Zhao Y, Ishino S, Palmisano A, Boeykens G, Meerwaldt AE, Sanchez-Gaytan BL, Baxter S, ... ... Lewis JS, et al. Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis. Jacc. Cardiovascular Imaging. PMID 30343086 DOI: 10.1016/J.Jcmg.2018.07.027  0.575
2018 Henry KE, Dacek MM, Dilling TR, Caen JD, Fox IL, Evans MJ, Lewis JS. A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30228208 DOI: 10.1158/1078-0432.Ccr-18-1485  0.8
2018 Brand C, Sadique A, Houghton JL, Gangangari K, Ponte JF, Lewis JS, Pillarsetty NVK, Konner JA, Reiner T. Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate. Ejnmmi Research. 8: 87. PMID 30155674 DOI: 10.1186/S13550-018-0437-X  0.634
2018 Henry KE, Ulaner GA, Lewis JS. Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer. Pet Clinics. 13: 423-435. PMID 30100080 DOI: 10.1016/J.Cpet.2018.02.010  0.769
2018 McKnight BN, Kuda-Wedagedara ANW, Sevak KK, Abdel-Atti D, Wiesend WN, Ku A, Selvakumar D, Carlin SD, Lewis JS, Viola-Villegas NT. Imaging EGFR and HER3 through Zr-labeled MEHD7945A (Duligotuzumab). Scientific Reports. 8: 9043. PMID 29899472 DOI: 10.1038/S41598-018-27454-6  0.398
2018 McDevitt MR, Thorek DLJ, Hashimoto T, Gondo T, Veach DR, Sharma SK, Kalidindi TM, Abou DS, Watson PA, Beattie BJ, Timmermand OV, Strand SE, Lewis JS, Scardino PT, Scher HI, et al. Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer. Nature Communications. 9: 1629. PMID 29691406 DOI: 10.1038/S41467-018-04107-W  0.3
2018 Vargas HA, Kramer GM, Scott AM, Weickhardt A, Meier AA, Parada N, Beattie BJ, Humm JL, Staton KD, Zanzonico PB, Lyashchenko SK, Lewis JS, Yaqub M, Sosa RE, van den Eertwegh AJ, et al. Reproducibility and repeatability of semi-quantitativeF-fluorodihydrotestosterone (FDHT) uptake metrics in castration-resistant prostate cancer metastases: a prospective multi-center study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29626121 DOI: 10.2967/Jnumed.117.206490  0.335
2018 Jannetti SA, Carlucci G, Carney B, Kossatz S, Shenker L, Carter LM, Salinas B, Brand C, Sadique A, Donabedian PL, Cunanan KM, Gönen M, Ponomarev V, Zeglis BM, Souweidane MM, ... Lewis JS, et al. PARP1-Targeted Radiotherapy in Mouse Models of Glioblastoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29572254 DOI: 10.2967/Jnumed.117.205054  0.724
2018 Escorcia FE, Steckler JM, Abdel-Atti D, Price EW, Carlin SD, Scholz WW, Lewis JS, Houghton JL. Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 29508263 DOI: 10.1007/S11307-018-1177-Z  0.438
2018 Membreno R, Cook BE, Fung K, Lewis JS, Zeglis BM. Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma. Molecular Pharmaceutics. PMID 29502416 DOI: 10.1021/Acs.Molpharmaceut.8B00093  0.651
2018 Pereira PMR, Abma L, Henry KE, Lewis JS. Imaging of human epidermal growth factor receptors for patient selection and response monitoring - From PET imaging and beyond. Cancer Letters. 419: 139-151. PMID 29414302 DOI: 10.1016/J.Canlet.2018.01.052  0.765
2018 Carter LM, Poty S, Sharma SK, Lewis JS. Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 29412489 DOI: 10.1002/Jlcr.3612  0.361
2018 Poty S, Membreno R, Glaser JM, Ragupathi A, Scholz WW, Zeglis BM, Lewis JS. The inverse electron-demand Diels-Alder reaction as a new methodology for the synthesis of 225Ac-labelled radioimmunoconjugates. Chemical Communications (Cambridge, England). PMID 29388990 DOI: 10.1039/C7Cc09129J  0.572
2018 Dunphy MPS, Harding JJ, Venneti S, Zhang H, Burnazi EM, Bromberg J, Omuro AM, Hsieh JJ, Mellinghoff IK, Staton K, Pressl C, Beattie BJ, Zanzonico PB, Gerecitano JF, Kelsen DP, ... ... Lewis JS, et al. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R )-4-Fluoroglutamine. Radiology. 162610. PMID 29388903 DOI: 10.1148/Radiol.2017162610  0.413
2018 Meyer JP, Tully KM, Jackson J, Dilling TR, Reiner T, Lewis JS. Bioorthogonal masking of circulating antibody-TCO groups using tetrazine-functionalized dextran polymers. Bioconjugate Chemistry. PMID 29378403 DOI: 10.1021/Acs.Bioconjchem.8B00028  0.815
2018 Sharma SK, Chow A, Monette S, Vivier D, Pourat J, Edwards KJ, Dilling TR, Abdel-Atti D, Zeglis BM, Poirier JT, Lewis JS. Fc-mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. Cancer Research. PMID 29363548 DOI: 10.1158/0008-5472.Can-17-1958  0.793
2018 Postow MA, Harding JJ, Hellmann MD, Gordon MS, Tsai F, O' Donoghue JA, Lewis JS, Wu AM, Le W, Korn RL, Weber W, Wolchok JD, Pandit-Taskar N. Imaging of tumor infiltrating T cells with an anti-CD8 minibody (Mb) 89Zr-IAB22M2C, in advanced solid tumors. Journal of Clinical Oncology. 36: e24160-e24160. DOI: 10.1200/Jco.2018.36.15_Suppl.E24160  0.305
2018 Suzuki M, Xu H, Guo H, Nemieboka B, Wu Z, Lewis J, Cheung NV. Abstract A30: Novel T-cell engaging antibodies against L1CAM for neuroblastoma Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-A30  0.347
2018 O'Reilly EA, Lohrmann C, O'Donoghue JA, Borazanci E, Estrella H, Teng R, Melink T, Dorr K, Kearns C, Peterson M, Ostrowski J, Gutheil J, Maffuid PW, Lewis JS, Weber W. Abstract CT140: Phase I dose escalation study of 177Lu-HuMab-5B1 (MVT-1075) in combination with MVT-5873 as radioimmunotherapy (RIT) in subjects with relapsed / refractory pancreatic cancer or other CA19-9+ malignancies Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ct140  0.329
2018 Evans MJ, Truillet C, Ruggero D, Lewis JS, Aggarwal R, Behr SC. Abstract 3694: Measuring oncogene signaling with transferrin-based PET: From bench to bedside Cancer Research. 78: 3694-3694. DOI: 10.1158/1538-7445.Am2018-3694  0.375
2018 Jun HT, Lohrmann C, Allaj V, Scholz W, Rainey GJ, Weber WA, Lewis JS, Poirier J, Maffuid PW. Abstract A062: Using CA19-9 as a translational biomarker for sLea targeted agents MVT-5873 and MVT-1075 in cancer Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A062  0.329
2017 Heinzmann K, Carter LM, Lewis JS, Aboagye EO. Multiplexed imaging for diagnosis and therapy. Nature Biomedical Engineering. 1: 697-713. PMID 31015673 DOI: 10.1038/S41551-017-0131-8  0.372
2017 Keinänen O, Fung K, Pourat J, Jallinoja V, Vivier D, Pillarsetty NK, Airaksinen AJ, Lewis JS, Zeglis BM, Sarparanta M. Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models. Ejnmmi Research. 7: 95. PMID 29198065 DOI: 10.1186/S13550-017-0344-6  0.782
2017 Ulaner GA, Lyashchenko SK, Riedl C, Ruan S, Zanzonico PB, Lake D, Jhaveri K, Zeglis B, Lewis JS, O'Donoghue JA. First-in-human HER2-targeted imaging using (89)Zr-pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29146695 DOI: 10.2967/Jnumed.117.202010  0.662
2017 Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW, Lewis JS, Solomon SB, Osborne JR, Veach D, Sawyers CL, et al. Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. Jama Oncology. e173588. PMID 29121144 DOI: 10.1001/Jamaoncol.2017.3588  0.375
2017 Anderson CJ, Lewis JS. Current status and future challenges for molecular imaging. Philosophical Transactions. Series a, Mathematical, Physical, and Engineering Sciences. 375. PMID 29038378 DOI: 10.1098/Rsta.2017.0023  0.318
2017 Kramer K, Pandit-Taskar N, Humm JL, Zanzonico PB, Haque S, Dunkel IJ, Wolden SL, Donzelli M, Goldman DA, Lewis JS, Lyashchenko SK, Khakoo Y, Carrasquillo JA, Souweidane MM, Greenfield JP, et al. A phase II study of radioimmunotherapy with intraventricular (131) I-3F8 for medulloblastoma. Pediatric Blood & Cancer. PMID 28940863 DOI: 10.1002/Pbc.26754  0.306
2017 Ulaner GA, Hyman DM, Lyashchenko SK, Lewis JS, Carrasquillo JA. 89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer. Clinical Nuclear Medicine. PMID 28872549 DOI: 10.1097/Rlu.0000000000001820  0.342
2017 Meyer JP, Kozlowski P, Jackson J, Cunanan KM, Adumeau P, Dilling TR, Zeglis BM, Lewis JS. Exploring Structural Parameters for Pretargeting Radioligand Optimization. Journal of Medicinal Chemistry. PMID 28857566 DOI: 10.1021/Acs.Jmedchem.7B01108  0.801
2017 Henry KE, Dilling TR, Abdel-Atti D, Edwards KJ, Evans MJ, Lewis JS. Non-invasive (89)Zr-Transferrin PET Shows Improved Tumor Targeting Compared to (18)F-FDG PET in MYC-overexpressing Human Triple Negative Breast Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28848040 DOI: 10.2967/Jnumed.117.192286  0.814
2017 Tang J, Salloum D, Carney B, Brand C, Kossatz S, Sadique A, Lewis JS, Weber WA, Wendel HG, Reiner T. Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 28827325 DOI: 10.1073/Pnas.1705013114  0.609
2017 Cornelis FH, Durack J, Pandit-Taskar N, Ulaner GA, Lewis JS, Morris MJ, Solomon SB. Long Half-life (89)Zr Labeled Radiotracers Can Guide In Suite Percutaneous Molecular Imaging PET/CT-guided Biopsies Without Reinjection of Radiotracer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28818992 DOI: 10.2967/Jnumed.117.194480  0.368
2017 Pandit-Taskar N, Zanzonico PB, Staton KD, Carrasquillo JA, Reidy-Lagunes D, Lyashchenko SK, Burnazi E, Zhang H, Lewis JS, Blasberg R, Larson SM, Weber WA, Modak S. Biodistribution and dosimetry of (18)F-Meta Fluorobenzyl Guanidine (MFBG): A first-in-human PET-CT imaging study of patients with neuroendocrine malignancies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28705916 DOI: 10.2967/Jnumed.117.193169  0.395
2017 O'Donoghue JA, Lewis JS, Pandit-Taskar N, Fleming SE, Schoder H, Larson SM, Beylergil V, Ruan S, Lyashchenko S, Zanzonico PB, Weber WA, Carrasquillo JA, Janjigian YY. Pharmacokinetics, biodistribution, and radiation dosimetry for (89)Zr-trastuzumab in patients with esophagogastric cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28637800 DOI: 10.2967/Jnumed.117.194555  0.394
2017 Rao TD, Fernández-Tejada A, Axelrod A, Rosales N, Yan X, Thapi S, Wang A, Park KJ, Nemieboka B, Xiang J, Lewis JS, Olvera N, Levine DA, Danishefsky SJ, Spriggs D. Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth. Acs Chemical Biology. PMID 28617578 DOI: 10.1021/Acschembio.7B00305  0.336
2017 Henry KE, Ulaner GA, Lewis JS. Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer: Noninvasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis. Pet Clinics. 12: 269-288. PMID 28576166 DOI: 10.1016/J.Cpet.2017.02.001  0.782
2017 Sharma SK, Pourat J, Abdel-Atti D, Carlin SD, Piersigilli A, Bankovich AJ, Gardner EE, Hamdy O, Isse K, Bheddah S, Sandoval J, Cunanan KM, Johansen EB, Allaj V, Sisodiya V, ... ... Lewis JS, et al. Non-invasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer. Cancer Research. PMID 28487384 DOI: 10.1158/0008-5472.Can-17-0299  0.68
2017 Wyatt LC, Lewis JS, Andreev OA, Reshetnyak YK, Engelman DM. Applications of pHLIP Technology for Cancer Imaging and Therapy. Trends in Biotechnology. PMID 28438340 DOI: 10.1016/J.Tibtech.2017.03.014  0.403
2017 Di Gialleonardo V, Aldeborgh HN, Miloushev V, Folkers KM, Granlund K, Tap WD, Lewis JS, Weber WA, Keshari K. Multinuclear NMR and MRI reveal an early metabolic response to mTOR inhibition in sarcoma. Cancer Research. PMID 28386017 DOI: 10.1158/0008-5472.Can-16-3310  0.323
2017 Price EW, Carnazza KE, Carlin SD, Cho A, Edwards KJ, Sevak KK, Glaser JM, de Stanchina E, Janjigian YY, Lewis JS. (89)Zr-DFO-AMG102 Immuno-PET to Determine Local HGF Protein Levels in Tumors for Enhanced Patient Selection. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28280216 DOI: 10.2967/Jnumed.116.187310  0.426
2017 Houghton JL, Abdel-Atti D, Scholz WW, Lewis JS. Preloading with unlabeled CA19.9 targeted human monoclonal antibody leads to improved PET imaging with 89Zr‑5B1. Molecular Pharmaceutics. PMID 28191976 DOI: 10.1021/Acs.Molpharmaceut.6B01130  0.436
2017 Houghton JL, Membreno R, Abdel-Atti D, Cunanan KM, Carlin S, Scholz WW, Zanzonico PB, Lewis JS, Zeglis BM. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry. Molecular Cancer Therapeutics. 16: 124-133. PMID 28062708 DOI: 10.1158/1535-7163.Mct-16-0503  0.682
2017 Houghton JL, Lanning R, Abdel-atti D, Jun T, Kearns CM, Schlosser M, Scholz W, Lewis JS, Maffuid PW. Abstract 5204: Preclinical development of MVT-1075 as radioimmunotherapy for pancreatic cancer and other CA19-9 positive malignancies Cancer Research. 77: 5204-5204. DOI: 10.1158/1538-7445.Am2017-5204  0.376
2017 Kramer K, Kushner B, Modak S, Pandit-Taskar N, Tomlinson U, Donzelli M, Wolden S, Zanzonico P, Humm J, Haque S, Souweidane M, Greenfield J, Basu E, Roberts S, Carrasquillo J, Lewis J, et al. SCDT-38. SAFETY AND EFFICACY OF INTRAVENTRICULAR 131I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE Neuro-Oncology. 19: vi272-vi272. DOI: 10.1093/Neuonc/Nox168.1119  0.331
2016 Truillet C, Cunningham JT, Parker MF, Huynh LT, Conn CS, Ruggero D, Lewis JS, Evans MJ. Non-invasive measurement of mTORC1 signaling with 89Zr-transferrin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28007777 DOI: 10.1158/1078-0432.Ccr-16-2448  0.308
2016 Adumeau P, Carnazza KE, Brand C, Carlin SD, Reiner T, Agnew BJ, Lewis JS, Zeglis BM. A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer. Theranostics. 6: 2267-2277. PMID 27924162 DOI: 10.7150/Thno.16744  0.772
2016 Thorek DL, Watson PA, Lee SG, Ku AT, Bournazos S, Braun K, Kim K, Sjöström K, Doran MG, Lamminmäki U, Santos E, Veach D, Turkekul M, Casey E, Lewis JS, et al. Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis. Science Translational Medicine. 8: 367ra167. PMID 27903863 DOI: 10.1126/Scitranslmed.Aaf2335  0.375
2016 Ulaner GA, Goldman D, Corben A, Lyashchenko S, Gonen M, Lewis J, Dickler M. A prospective clinical trial of 18F-Fluciclovine PET/CT neoadjuvant therapy response in invasive ductal and invasive lobular breast cancers. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27856630 DOI: 10.2967/Jnumed.116.183335  0.365
2016 Meyer JP, Adumeau P, Lewis JS, Zeglis BM. Click Chemistry and Radiochemistry: The First Ten Years. Bioconjugate Chemistry. PMID 27787983 DOI: 10.1021/Acs.Bioconjchem.6B00561  0.622
2016 O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, ... ... Lewis JS, et al. Imaging biomarker roadmap for cancer studies. Nature Reviews. Clinical Oncology. PMID 27725679 DOI: 10.1038/Nrclinonc.2016.162  0.334
2016 Pandit-Taskar N, O'Donoghue JA, Ruan S, Lyashchenko S, Carrasquillo JA, Heller G, Martinez DF, Cheal SM, Lewis JS, Fleisher M, Keppler JS, Reiter RE, Wu AM, Weber WA, Scher HI, et al. First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27516450 DOI: 10.2967/Jnumed.116.176206  0.334
2016 Demoin DW, Shindo M, Zhang H, Edwards KJ, Serganova I, Pillarsetty NV, Lewis JS, Blasberg RG. Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas. Nuclear Medicine and Biology. 43: 606-611. PMID 27485481 DOI: 10.1016/J.Nucmedbio.2016.05.005  0.328
2016 Price EW, Edwards KJ, Carnazza KE, Carlin SD, Zeglis BM, Adam MJ, Orvig C, Lewis JS. A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y. Nuclear Medicine and Biology. 43: 566-576. PMID 27419360 DOI: 10.1016/J.Nucmedbio.2016.06.004  0.588
2016 Demoin DW, Wyatt LC, Edwards KJ, Abdel-Atti D, Sarparanta MP, Pourat J, Longo VA, Carlin SD, Engelman DM, Andreev OA, Reshetnyak YK, Viola-Villegas N, Lewis JS. PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-labeled pHLIP peptides: A Structure-Activity Optimization Study. Bioconjugate Chemistry. PMID 27396694 DOI: 10.1021/Acs.Bioconjchem.6B00306  0.724
2016 Meyer JP, Edwards KJ, Kozlowski P, Backer MV, Backer JM, Lewis JS. Selective imaging of VEGFR-1 and VEGFR-2 receptors using 89Zr-labeled single-chain VEGF mutants. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27390161 DOI: 10.2967/Jnumed.116.173237  0.337
2016 Cook BE, Adumeau P, Membreno R, Carnazza KE, Brand C, Reiner T, Agnew BJ, Lewis JS, Zeglis BM. Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate. Bioconjugate Chemistry. PMID 27356886 DOI: 10.1021/Acs.Bioconjchem.6B00235  0.767
2016 Pérez-Medina C, Abdel-Atti D, Tang J, Zhao Y, Fayad ZA, Lewis JS, Mulder WJ, Reiner T. Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. Nature Communications. 7: 11838. PMID 27319780 DOI: 10.1038/Ncomms11838  0.618
2016 Pérez-Medina C, Binderup T, Lobatto ME, Tang J, Calcagno C, Giesen L, Wessel CH, Witjes J, Ishino S, Baxter S, Zhao Y, Ramachandran S, Eldib M, Sánchez-Gaytán BL, Robson PM, ... ... Lewis JS, et al. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. Jacc. Cardiovascular Imaging. PMID 27236528 DOI: 10.1016/J.Jcmg.2016.01.020  0.602
2016 Ulaner GA, Hyman D, Ross D, Corben A, Chandarlapaty S, Goldfarb S, McArthur H, Erinjeri J, Solomon S, Kolb H, Lyashchenko S, Lewis J, Carrasquillo J. Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using the 89Zr-DFO-trastuzumab PET/CT. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27151988 DOI: 10.2967/Jnumed.115.172031  0.362
2016 Sharma SK, Nemieboka B, Sala E, Lewis JS, Zeglis BM. Molecular Imaging of Ovarian Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27127223 DOI: 10.2967/Jnumed.115.172023  0.658
2016 Ulaner GA, Goldman D, Gonen M, Pham H, Castillo R, Lyashchenko S, Lewis J, Dang C. Initial results of a prospective clinical trial of 18F-Fluciclovine PET/CT in newly diagnosed invasive ductal and invasive lobular breast cancers. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26940766 DOI: 10.2967/Jnumed.115.170456  0.348
2016 Sharma SK, Sevak KK, Monette S, Carlin SD, Knight JC, Wuest FR, Sala E, Zeglis BM, Lewis JS. Preclinical 89Zr-immunoPET of High Grade Serous Ovarian Cancer and Lymph Node Metastasis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26837339 DOI: 10.2967/Jnumed.115.167072  0.626
2016 Taldone T, Zatorska D, Ochiana SO, Smith-Jones P, Koziorowski J, Dunphy MP, Zanzonico P, Bolaender A, Lewis JS, Larson SM, Chiosis G, Pillarsetty NV. Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 26806023 DOI: 10.1002/Jlcr.3369  0.335
2016 Doran MG, Carnazza KE, Steckler JM, Spratt DE, Truillet C, Wongvipat J, Sawyers CL, Lewis JS, Evans MJ. Applying 89Zr-transferrin to study the pharmacology of inhibitors to BET bromodomain containing proteins. Molecular Pharmaceutics. PMID 26725682 DOI: 10.1021/Acs.Molpharmaceut.5B00882  0.388
2016 Morris MJ, Martinez DF, Durack JC, Slovin SF, Danila DC, O' Donoghue JA, Parada NA, Lyashchenko SK, Carrasquillo JA, Ruan S, Lewis JS, Keppler J, Wu AM, Reuter VE, Weber W, et al. A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with 89Zr-Df-IAB2M in metastatic prostate cancer (PCa). Journal of Clinical Oncology. 34: 287-287. DOI: 10.1200/Jco.2016.34.2_Suppl.287  0.361
2016 Nemieboka BE, Thapi D, Bitton A, Lewis JS. Abstract B25: Preclinical evaluation of radiolabeled MUC16 antibodies for PET imaging of epithelial ovarian carcinoma. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B25  0.39
2016 Price EW, Glaser JM, Edwards KJ, Lewis JS. Abstract LB-182: Optimized antibody modification and radiolabeling conditions for zirconium-89 immuno-PET Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-182  0.402
2016 Demoin DW, Edwards KJ, Wyatt LC, Sarparanta M, Pourat J, Andreev OA, Reshetnyak YK, Viola-Villegas N, Lewis JS. Abstract 4205: Targeting a variety of cancers with NOTA-derivatized pH (low) insertion peptide (pHLIP) complexes with64Cu and18F: What cancers are targetable Cancer Research. 76: 4205-4205. DOI: 10.1158/1538-7445.Am2016-4205  0.735
2016 Houghton J, Membreno R, Abdel-Atti D, Scholz WW, Zeglis BM, Lewis JS. Abstract 3051: Improving the efficacy of pretargeted radioimmunotherapy in preclinical murine models by utilizing bioorthogonal click chemistry Cancer Research. 76: 3051-3051. DOI: 10.1158/1538-7445.Am2016-3051  0.665
2015 Houghton JL, Zeglis BM, Abdel-Atti D, Aggeler R, Sawada R, Agnew BJ, Scholz WW, Lewis JS. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 26668398 DOI: 10.1073/Pnas.1506542112  0.696
2015 Deri M, Ponnala S, Kozlowski P, Burton-Pye BP, Cicek H, Hu C, Lewis JS, Francesconi LC. p-SCN-BN-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET. Bioconjugate Chemistry. PMID 26550847 DOI: 10.1021/Acs.Bioconjchem.5B00572  0.392
2015 Meyer JP, Houghton JL, Kozlowski P, Abdel-Atti D, Reiner T, Pillarsetty NV, Scholz WW, Zeglis BM, Lewis JS. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry. Bioconjugate Chemistry. PMID 26479967 DOI: 10.1021/Acs.Bioconjchem.5B00504  0.742
2015 Houghton JL, Zeglis BM, Abdel-Atti D, Sawada R, Scholz WW, Lewis JS. Pretargeted immunoPET of pancreatic cancer: overcoming circulating antigen and antibody internalization to reduce radiation doses. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26471693 DOI: 10.2967/Jnumed.115.163824  0.663
2015 Spratt DE, Evans MJ, Davis BJ, Doran MG, Lee MX, Shah N, Wongvipat J, Carnazza KE, Klee GG, Polkinghorn W, Tindall DJ, Lewis JS, Sawyers CL. Androgen receptor upregulation mediates radioresistance after ionizing radiation. Cancer Research. PMID 26432404 DOI: 10.1158/0008-5472.Can-15-0892  0.301
2015 Zeglis BM, Brand C, Abdel-Atti D, Carnazza KE, Cook BE, Carlin S, Reiner T, Lewis JS. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics. Molecular Pharmaceutics. PMID 26287993 DOI: 10.1021/Acs.Molpharmaceut.5B00294  0.773
2015 Pandit-Taskar N, O'Donoghue JA, Durack JC, Lyashchenko SK, Cheal SM, Beylergil V, Lefkowitz RA, Carrasquillo JA, Martinez DF, Fung AM, Solomon SB, Gonen M, Heller G, Loda M, Nanus DM, ... ... Lewis JS, et al. A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26175541 DOI: 10.1158/1078-0432.Ccr-15-0552  0.377
2015 Perez-Medina C, Tang J, Abdel-Atti D, Hogstad B, Merad M, Fisher EA, Fayad ZA, Lewis JS, Mulder WJ, Reiner T. PET Imaging of Tumor-Associated Macrophages with 89Zr-labeled HDL Nanoparticles. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26112022 DOI: 10.2967/Jnumed.115.158956  0.637
2015 Dimastromatteo J, Houghton JL, Lewis JS, Kelly KA. Challenges of Pancreatic Cancer. Cancer Journal (Sudbury, Mass.). 21: 188-93. PMID 26049698 DOI: 10.1097/Ppo.0000000000000109  0.382
2015 Lazari M, Lyashchenko SK, Burnazi EM, Lewis JS, Michael van Dam R, Murphy JM. Fully-automated synthesis of 16β-(18)F-fluoro-5α-dihydrotestosterone (FDHT) on the ELIXYS radiosynthesizer. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 103: 9-14. PMID 26046518 DOI: 10.1016/J.Apradiso.2015.05.010  0.358
2015 Bosch A, Li Z, Bergamaschi A, Ellis H, Toska E, Prat A, Tao JJ, Spratt DE, Viola-Villegas NT, Castel P, Minuesa G, Morse N, Rodón J, Ibrahim Y, Cortes J, ... ... Lewis JS, et al. PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer. Science Translational Medicine. 7: 283ra51. PMID 25877889 DOI: 10.1126/Scitranslmed.Aaa4442  0.316
2015 Reiner T, Lewis JS, Zeglis BM. Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging. Journal of Visualized Experiments : Jove. e52335. PMID 25742199 DOI: 10.3791/52335  0.765
2015 Zeglis BM, Lewis JS. The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies. Journal of Visualized Experiments : Jove. PMID 25741890 DOI: 10.3791/52521  0.677
2015 Lapi SE, Lewis JS, Dehdashti F. Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone). Seminars in Nuclear Medicine. 45: 177-85. PMID 25704389 DOI: 10.1053/J.Semnuclmed.2014.10.003  0.354
2015 Venneti S, Dunphy MP, Zhang H, Pitter KL, Zanzonico P, Campos C, Carlin SD, La Rocca G, Lyashchenko S, Ploessl K, Rohle D, Omuro AM, Cross JR, Brennan CW, Weber WA, ... ... Lewis JS, et al. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo. Science Translational Medicine. 7: 274ra17. PMID 25673762 DOI: 10.1126/Scitranslmed.Aaa1009  0.393
2015 Morris MJ, Solomon SB, Durack JC, O' Donoghue JA, Lyashchenko SK, Shutian R, Carrasquillo JA, Lewis JS, Martinez DF, Parada NA, Keppler J, Wu A, Reuter VE, Weber W, Scher HI, et al. Pathologic correlation of 89Zr-Df-IAB2M antiprostate-specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer. Journal of Clinical Oncology. 33: 220-220. DOI: 10.1200/Jco.2015.33.7_Suppl.220  0.407
2015 Gerecitano JF, Modi S, Rampal R, Drilon AE, Fury MG, Gounder MM, Harding JJ, Hyman DM, Varghese AM, Voss MH, France FO, Taldone T, Gomes DaGama E, Uddin M, Chiosis G, Lewis JS, et al. Phase I trial of the HSP-90 inhibitor PU-H71. Journal of Clinical Oncology. 33: 2537-2537. DOI: 10.1200/Jco.2015.33.15_Suppl.2537  0.316
2015 Dunphy M, Harding JJ, Lewis JS, Mellinghoff IK, Omuro AMP, Hsieh J, Zhang H, Zanzonico P, Venneti S, Carlin S, Younes A, Gerecitano JF, Lyashchenko SK, Harris L, Lashley A, et al. Phenotypic correlation of tumor uptake of exogenous glutamine radiotracer versus tumor mutational status. Journal of Clinical Oncology. 33: 11014-11014. DOI: 10.1200/Jco.2015.33.15_Suppl.11014  0.38
2015 Lewis JS. Abstract IA16: New methods of PET imaging pancreas cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-Ia16  0.458
2015 Houghton JL, Abdel-Atti DA, Sawada R, Scholz WW, Lewis JS. Abstract B25: Development of 5B1, an anti-CA19.9 monoclonal antibody, as a near-infrared fluorescent probe for intraoperative imaging of pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B25  0.418
2015 Taldone T, Pillarsetty N, Dunphy MP, Gerecitano JF, Caldas-Lopes E, Beattie B, Peter RI, Kang Y, Rodina A, Yan P, Gomes EMD, Bolaender A, Pressl C, Punzalan B, Ku A, ... ... Lewis JS, et al. Abstract 5444: Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy Cancer Research. 75: 5444-5444. DOI: 10.1158/1538-7445.Am2015-5444  0.421
2015 Thorek D, Braun K, Lewis J, Scardino P, Lilja H, Larson S, Ulmert D. MP37-10 11B6 MAB: APPLICATIONS FOR PROSTATE CANCER STAGING, INTRA-OPERATIVE GUIDANCE AND EVALUATION OF TREATMENT BY IN VIVO IMAGING OF HK2 Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1273  0.344
2014 Contag C, Pogue B, Lewis J. MO-C-BRE-01: The WMIS-AAPM Joint Symposium: Advances in Molecular Imaging. Medical Physics. 41: 412. PMID 28036785 DOI: 10.1118/1.4889121  0.378
2014 Doran MG, Watson PA, Cheal SM, Spratt DE, Wongvipat J, Steckler JM, Carrasquillo JA, Evans MJ, Lewis JS. Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 2045-9. PMID 25453051 DOI: 10.2967/Jnumed.114.145185  0.332
2014 Zeglis BM, Davis CB, Abdel-Atti D, Carlin SD, Chen A, Aggeler R, Agnew BJ, Lewis JS. Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging. Bioconjugate Chemistry. 25: 2123-8. PMID 25418333 DOI: 10.1021/Bc500499H  0.685
2014 Daumar P, Zeglis BM, Ramos N, Divilov V, Sevak KK, Pillarsetty N, Lewis JS. Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression. European Journal of Medicinal Chemistry. 86: 769-81. PMID 25240701 DOI: 10.1016/J.Ejmech.2014.09.019  0.646
2014 Price EW, Zeglis BM, Cawthray JF, Lewis JS, Adam MJ, Orvig C. What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry. Inorganic Chemistry. 53: 10412-31. PMID 25192223 DOI: 10.1021/Ic501466Z  0.584
2014 Pandit-Taskar N, O'Donoghue JA, Beylergil V, Lyashchenko S, Ruan S, Solomon SB, Durack JC, Carrasquillo JA, Lefkowitz RA, Gonen M, Lewis JS, Holland JP, Cheal SM, Reuter VE, Osborne JR, et al. ⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 41: 2093-105. PMID 25143071 DOI: 10.1007/S00259-014-2830-7  0.644
2014 Pérez-Medina C, Abdel-Atti D, Zhang Y, Longo VA, Irwin CP, Binderup T, Ruiz-Cabello J, Fayad ZA, Lewis JS, Mulder WJ, Reiner T. A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1706-11. PMID 25060196 DOI: 10.2967/Jnumed.114.141861  0.605
2014 Adochite RC, Moshnikova A, Carlin SD, Guerrieri RA, Andreev OA, Lewis JS, Reshetnyak YK. Targeting breast tumors with pH (low) insertion peptides. Molecular Pharmaceutics. 11: 2896-905. PMID 25004202 DOI: 10.1021/Mp5002526  0.383
2014 Brand C, Abdel-Atti D, Zhang Y, Carlin S, Clardy SM, Keliher EJ, Weber WA, Lewis JS, Reiner T. In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent. Bioconjugate Chemistry. 25: 1323-30. PMID 24856928 DOI: 10.1021/Bc500178D  0.62
2014 Deri MA, Ponnala S, Zeglis BM, Pohl G, Dannenberg JJ, Lewis JS, Francesconi LC. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO). Journal of Medicinal Chemistry. 57: 4849-60. PMID 24814511 DOI: 10.1021/Jm500389B  0.663
2014 Zeglis BM, Emmetiere F, Pillarsetty N, Weissleder R, Lewis JS, Reiner T. Building Blocks for the Construction of Bioorthogonally Reactive Peptides via Solid-Phase Peptide Synthesis. Chemistryopen. 3: 48-53. PMID 24808990 DOI: 10.1002/Open.201402000  0.681
2014 Viola-Villegas NT, Carlin SD, Ackerstaff E, Sevak KK, Divilov V, Serganova I, Kruchevsky N, Anderson M, Blasberg RG, Andreev OA, Engelman DM, Koutcher JA, Reshetnyak YK, Lewis JS. Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 111: 7254-9. PMID 24785505 DOI: 10.1073/Pnas.1405240111  0.385
2014 Viola-Villegas NT, Sevak KK, Carlin SD, Doran MG, Evans HW, Bartlett DW, Wu AM, Lewis JS. Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives. Molecular Pharmaceutics. 11: 3965-73. PMID 24779727 DOI: 10.1021/Mp500164R  0.425
2014 Tao JJ, Castel P, Radosevic-Robin N, Elkabets M, Auricchio N, Aceto N, Weitsman G, Barber P, Vojnovic B, Ellis H, Morse N, Viola-Villegas NT, Bosch A, Juric D, Hazra S, ... ... Lewis JS, et al. Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer. Science Signaling. 7: ra29. PMID 24667376 DOI: 10.1126/Scisignal.2005125  0.303
2014 Cheal SM, Punzalan B, Doran MG, Evans MJ, Osborne JR, Lewis JS, Zanzonico P, Larson SM. Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 41: 985-94. PMID 24604591 DOI: 10.1007/S00259-013-2679-1  0.365
2014 Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2182-91. PMID 24573553 DOI: 10.1158/1078-0432.Ccr-13-1153  0.357
2014 Zeglis BM, Houghton JL, Evans MJ, Viola-Villegas N, Lewis JS. Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals. Inorganic Chemistry. 53: 1880-99. PMID 24313747 DOI: 10.1021/Ic401607Z  0.631
2014 Zhang H, Huang R, Pillarsetty N, Thorek DL, Vaidyanathan G, Serganova I, Blasberg RG, Lewis JS. Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter. European Journal of Nuclear Medicine and Molecular Imaging. 41: 322-32. PMID 24173571 DOI: 10.1007/S00259-013-2558-9  0.388
2014 Osborne JR, Green DA, Spratt DE, Lyashchenko S, Fareedy SB, Robinson BD, Beattie BJ, Jain M, Lewis JS, Christos P, Larson SM, Bander NH, Scherr DS. A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy. The Journal of Urology. 191: 1439-45. PMID 24135437 DOI: 10.1016/J.Juro.2013.10.041  0.31
2014 Price EW, Zeglis BM, Lewis JS, Adam MJ, Orvig C. H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu. Dalton Transactions (Cambridge, England : 2003). 43: 119-31. PMID 24104523 DOI: 10.1039/C3Dt51940F  0.65
2014 Morris MJ, Pandit-Taskar N, Tagawa ST, Nanus DM, Solomon SB, Carrasquillo JA, Reuter VE, Lewis JS, Beylergil V, O' Donoghue JA, Lyashchenko SK, Martinez DF, Curtis KR, Durack JC, Cheal SM, et al. Tumor-directed PET imaging of bone metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled anti-prostate specific membrane antigen (PSMA) antibody J591. Journal of Clinical Oncology. 32: 25-25. DOI: 10.1200/Jco.2014.32.4_Suppl.25  0.404
2014 Olafsen T, Bartlett D, Ho D, Zhang G, Torgov M, Keppler J, Behrenbruch C, Wu A, Pandit-Taskar N, Morris MJ, Lewis JS, Lyashchenko SK, Gudas JM. Minibody imaging of prostate-specific membrane antigen (PSMA): From concept to clinic. Journal of Clinical Oncology. 32: e16057-e16057. DOI: 10.1200/Jco.2014.32.15_Suppl.E16057  0.422
2014 Venneti S, Dunphy M, Zhang H, Pitter K, Campos C, Carlin S, Lyashchenko S, Ploessl C, Rohle D, Omuro A, Cross J, Brennan C, Weber W, Holland E, Mellinghoff I, ... Lewis J, et al. TM-15 * GLUTAMINE BASED PET IMAGING FACILITATES ENHANCED METABOLIC DETECTION OF GLIOMAS IN VIVO Neuro-Oncology. 16: v216-v216. DOI: 10.1093/Neuonc/Nou278.14  0.381
2014 Sharma SK, Zeglis B, Sevak K, Lewis J, Wuest F. 89Zr immuno-PET of epithelial ovarian cancer Nuclear Medicine and Biology. 41: 638-639. DOI: 10.1016/J.Nucmedbio.2014.05.114  0.627
2014 Zeglis BM, Davis CB, Aggeler R, Agnew BJ, Lewis JS. The site-specific radiometallation of antibodies on the heavy chain glycans Nuclear Medicine and Biology. 41: 636. DOI: 10.1016/J.Nucmedbio.2014.05.110  0.577
2014 Deri MA, Ponnala S, Zeglis BM, Pohl G, Dannenberg JJ, Lewis JS, Francesconi LC. 3,4,3-(LI-1,2-HOPO): An alternative chelator for 89Zr radiopharmaceuticals Nuclear Medicine and Biology. 41: 629. DOI: 10.1016/J.Nucmedbio.2014.05.103  0.568
2014 Price EW, Zeglis BM, Cawthray JF, Lewis JS, Adam MJ, Orvig C. H4octapa vs H4C3octapa: The difference of a single carbon atom Nuclear Medicine and Biology. 41: 635. DOI: 10.1016/J.Nucmedbio.2014.05.032  0.536
2014 Spratt D, Doran M, Wongvipat J, Lewis J, Evans M. 89Zr-MSTP2109A, A Novel Antibody Based Radiotracer to Evaluate and Guide the Clinical Translation of Antibody-Drug Conjugates Targeting STEAP1 International Journal of Radiation Oncology*Biology*Physics. 90: S791. DOI: 10.1016/J.Ijrobp.2014.05.2286  0.323
2014 Zeng D, Zeglis BM, Lewis JS, Anderson CJ. ChemInform Abstract: The Growing Impact of Bioorthogonal Click Chemistry on the Development of Radiopharmaceuticals Cheminform. 45: no-no. DOI: 10.1002/CHIN.201439276  0.524
2013 Pandit-Taskar N, Carrasquillo JA, O' Donoghue JA, Humm J, Lyashchenko SK, Haupt EC, Bander NH, Tagawa ST, Holland JP, Smith-Jones PM, Lewis JS, Solomon SB, Scher HI, Larson SM. Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 31. PMID 28136972 DOI: 10.1200/Jco.2013.31.6_Suppl.31  0.628
2013 Emmetiere F, Irwin C, Viola-Villegas NT, Longo V, Cheal SM, Zanzonico P, Pillarsetty N, Weber WA, Lewis JS, Reiner T. (18)F-labeled-bioorthogonal liposomes for in vivo targeting. Bioconjugate Chemistry. 24: 1784-9. PMID 24180480 DOI: 10.1021/Bc400322H  0.627
2013 Viola-Villegas NT, Rice SL, Carlin S, Wu X, Evans MJ, Sevak KK, Drobjnak M, Ragupathi G, Sawada R, Scholz WW, Livingston PO, Lewis JS. Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1876-82. PMID 24029655 DOI: 10.2967/Jnumed.113.119867  0.31
2013 Gemignani ML, Patil S, Seshan VE, Sampson M, Humm JL, Lewis JS, Brogi E, Larson SM, Morrow M, Pandit-Taskar N. Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1697-702. PMID 23970364 DOI: 10.2967/Jnumed.112.113373  0.326
2013 Price EW, Zeglis BM, Cawthray JF, Ramogida CF, Ramos N, Lewis JS, Adam MJ, Orvig C. H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy. Journal of the American Chemical Society. 135: 12707-21. PMID 23901833 DOI: 10.1021/Ja4049493  0.687
2013 Yoshii Y, Furukawa T, Oyama N, Hasegawa Y, Kiyono Y, Nishii R, Waki A, Tsuji AB, Sogawa C, Wakizaka H, Fukumura T, Yoshii H, Fujibayashi Y, Lewis JS, Saga T. Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome. Plos One. 8: e64570. PMID 23741342 DOI: 10.1371/Journal.Pone.0064570  0.389
2013 Zeglis BM, Sevak KK, Reiner T, Mohindra P, Carlin SD, Zanzonico P, Weissleder R, Lewis JS. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1389-96. PMID 23708196 DOI: 10.2967/Jnumed.112.115840  0.756
2013 Zeglis BM, Davis CB, Aggeler R, Kang HC, Chen A, Agnew BJ, Lewis JS. Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry. Bioconjugate Chemistry. 24: 1057-67. PMID 23688208 DOI: 10.1021/Bc400122C  0.636
2013 Zeng D, Zeglis BM, Lewis JS, Anderson CJ. The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 829-32. PMID 23616581 DOI: 10.2967/Jnumed.112.115550  0.634
2013 Janjigian YY, Viola-Villegas N, Holland JP, Divilov V, Carlin SD, Gomes-DaGama EM, Chiosis G, Carbonetti G, de Stanchina E, Lewis JS. Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 936-43. PMID 23578997 DOI: 10.2967/Jnumed.112.110239  0.616
2013 Evans MJ, Holland JP, Rice SL, Doran MG, Cheal SM, Campos C, Carlin SD, Mellinghoff IK, Sawyers CL, Lewis JS. Imaging tumor burden in the brain with 89Zr-transferrin. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 90-5. PMID 23236019 DOI: 10.2967/Jnumed.112.109777  0.596
2013 Abou DS, Thorek DL, Ramos NN, Pinkse MW, Wolterbeek HT, Carlin SD, Beattie BJ, Lewis JS. (89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer. Pharmaceutical Research. 30: 878-88. PMID 23224977 DOI: 10.1007/S11095-012-0929-8  0.429
2013 Deri MA, Zeglis BM, Francesconi LC, Lewis JS. PET imaging with ⁸⁹Zr: from radiochemistry to the clinic. Nuclear Medicine and Biology. 40: 3-14. PMID 22998840 DOI: 10.1016/J.Nucmedbio.2012.08.004  0.666
2013 Slovin SF, Wang X, Hullings M, Arauz G, Bartido S, Lewis JS, Schöder H, Zanzonico P, Scher HI, Riviere I. Chimeric antigen receptor (CAR+) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC). Journal of Clinical Oncology. 31: 72-72. DOI: 10.1200/Jco.2013.31.15_Suppl.Tps3115  0.335
2013 Gerecitano JF, Modi S, Gajria D, Taldone T, Alpaugh M, Gomes DaGama E, Uddin M, Chiosis G, Lewis JS, Larson SM, Pillarsetty NVK, Jhaveri KL, Krichevsky B, Chen MH, Dixit P, et al. Using 124I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71. Journal of Clinical Oncology. 31: 11076-11076. DOI: 10.1200/Jco.2013.31.15_Suppl.11076  0.341
2013 Wagar M, Mannarino E, Williams C, Hacker F, Berbeco R, Lewis J. SU-E-J-141: A Patient Specific Anthropomorphic Breathing Phantom for Clinically Realistic Imaging and Dosimetry Studies Medical Physics. 40: 183-183. DOI: 10.1118/1.4814353  0.361
2013 Zeglis BM, Holland JP, Lebedev AY, Cantorias MV, Lewis JS. Radiopharmaceuticals for imaging in oncology with special emphasis on positron-emitting agents Nuclear Oncology: Pathophysiology and Clinical Applications. 35-78. DOI: 10.1007/978-0-387-48894-3_3  0.76
2012 Bailey GA, Price EW, Zeglis BM, Ferreira CL, Boros E, Lacasse MJ, Patrick BO, Lewis JS, Adam MJ, Orvig C. H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu. Inorganic Chemistry. 51: 12575-89. PMID 23106422 DOI: 10.1021/Ic302225Z  0.602
2012 Holland JP, Evans MJ, Rice SL, Wongvipat J, Sawyers CL, Lewis JS. Annotating MYC status with 89Zr-transferrin imaging. Nature Medicine. 18: 1586-91. PMID 23001181 DOI: 10.1038/Nm.2935  0.638
2012 Zhang H, Cantorias MV, Pillarsetty N, Burnazi EM, Cai S, Lewis JS. An improved strategy for the synthesis of [¹⁸F]-labeled arabinofuranosyl nucleosides. Nuclear Medicine and Biology. 39: 1182-8. PMID 22819195 DOI: 10.1016/J.Nucmedbio.2012.06.008  0.305
2012 Daumar P, Wanger-Baumann CA, Pillarsetty N, Fabrizio L, Carlin SD, Andreev OA, Reshetnyak YK, Lewis JS. Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation. Bioconjugate Chemistry. 23: 1557-66. PMID 22784215 DOI: 10.1021/Bc3000222  0.339
2012 Ulmert D, Evans MJ, Holland JP, Rice SL, Wongvipat J, Pettersson K, Abrahamsson PA, Scardino PT, Larson SM, Lilja H, Lewis JS, Sawyers CL. Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen. Cancer Discovery. 2: 320-7. PMID 22576209 DOI: 10.1158/2159-8290.Cd-11-0316  0.609
2012 Dunphy MP, Zanzonico P, Veach D, Somwar R, Pillarsetty N, Lewis J, Larson S. Dosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 25-31. PMID 21161687 DOI: 10.1007/S11307-010-0462-2  0.404
2012 Modak S, Carrasquillo JA, La Quaglia MP, Zanzonico P, Pandit-Taskar N, Lewis JS, Cheung NV. Intraperitoneal radioimmunotherapy (RIT) for desmoplastic small round cell tumor (DSRCT). Journal of Clinical Oncology. 30: TPS9595-TPS9595. DOI: 10.1200/Jco.2012.30.15_Suppl.Tps9595  0.386
2012 Larson SM, Fox J, Morris M, Evans M, Lewis J, Humm J, Sawyers CL, Scher HI. Abstract IA22: Molecular Imaging of androgen receptor signalling in CRPC Cancer Research. 72: IA22-IA22. DOI: 10.1158/1538-7445.Prca2012-Ia22  0.422
2012 Rodina A, Moulick K, Ahn J, Zong H, Cerchietti L, DaGama EG, Caldas-Lopes E, Beebe K, Perna F, Hatzi K, Vu L, Zhao X, Zatorska D, Taldone T, Smith-Jones P, ... ... Lewis J, et al. Abstract 3029: Biochemical evidence towards the existence of an oncogenic Hsp90 complex Cancer Research. 72: 3029-3029. DOI: 10.1158/1538-7445.Am2012-3029  0.309
2012 Gomes-DaGama EM, Moulick K, Ahn JH, Zong H, Rodina A, Cerchietti L, Lopes-Vazquez MEC, Beebe K, Perna F, Katerina C, Vu LP, Zhao X, Zatorska D, Taldone T, Smith-Jones P, ... ... Lewis JS, et al. Abstract 1263: Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90 Cancer Research. 72: 1263-1263. DOI: 10.1158/1538-7445.Am2012-1263  0.353
2011 Janjigian YY, Villegas NT, Holland JP, Shah MA, Divilov V, Kelsen DP, Lewis JS. Positron emission tomography (PET) with (89)Zr-labeled trastuzumab ((89)Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 35. PMID 27985695 DOI: 10.1200/Jco.2011.29.4_Suppl.35  0.616
2011 Keliher EJ, Yoo J, Nahrendorf M, Lewis JS, Marinelli B, Newton A, Pittet MJ, Weissleder R. 89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. Bioconjugate Chemistry. 22: 2383-9. PMID 22035047 DOI: 10.1021/Bc200405D  0.388
2011 Moulick K, Ahn JH, Zong H, Rodina A, Cerchietti L, Gomes DaGama EM, Caldas-Lopes E, Beebe K, Perna F, Hatzi K, Vu LP, Zhao X, Zatorska D, Taldone T, Smith-Jones P, ... Lewis JS, et al. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nature Chemical Biology. 7: 818-26. PMID 21946277 DOI: 10.1038/Nchembio.670  0.341
2011 Ruggiero A, Holland JP, Hudolin T, Shenker L, Koulova A, Bander NH, Lewis JS, Grimm J. Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1608-15. PMID 21908391 DOI: 10.2967/Jnumed.111.092098  0.633
2011 Zeglis BM, Mohindra P, Weissmann GI, Divilov V, Hilderbrand SA, Weissleder R, Lewis JS. Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry. Bioconjugate Chemistry. 22: 2048-59. PMID 21877749 DOI: 10.1021/Bc200288D  0.649
2011 Zeglis BM, Pillarsetty N, Divilov V, Blasberg RA, Lewis JS. The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer. Nuclear Medicine and Biology. 38: 683-96. PMID 21718944 DOI: 10.1016/J.Nucmedbio.2010.12.008  0.623
2011 Rice SL, Roney CA, Daumar P, Lewis JS. The next generation of positron emission tomography radiopharmaceuticals in oncology Seminars in Nuclear Medicine. 41: 265-282. PMID 21624561 DOI: 10.1053/J.Semnuclmed.2011.02.002  0.39
2011 Holland JP, Normand G, Ruggiero A, Lewis JS, Grimm J. Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions. Molecular Imaging. 10: 177-86, 1-3. PMID 21496448 DOI: 10.2310/7290.2010.00047S  0.67
2011 Zeglis BM, Lewis JS. A practical guide to the construction of radiometallated bioconjugates for positron emission tomography. Dalton Transactions (Cambridge, England : 2003). 40: 6168-95. PMID 21442098 DOI: 10.1039/C0Dt01595D  0.677
2011 Heneweer C, Holland JP, Divilov V, Carlin S, Lewis JS. Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 625-633. PMID 21421727 DOI: 10.2967/Jnumed.110.083998  0.625
2011 Zeglis BM, Divilov V, Lewis JS. Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes. Journal of Medicinal Chemistry. 54: 2391-8. PMID 21391686 DOI: 10.1021/Jm101532U  0.592
2011 Arrowsmith RL, Zeglis BM, Viola-Villegas N, Divilov, Jones M, Waghorn PA, Phillips FL, Mindt TL, Eggleston IM, Botchway SW, Dilworth JR, Aigbirhio FI, Lewis JS, Pascu SI. Fluorescent copper(II), gallium(III) and indium(III) bis(thiosemicarbazonates):Radiolabeling, cellular confocal fluorescence and PET imaging studies Journal of Labelled Compounds and Radiopharmaceuticals. 54. DOI: 10.1002/Jlcr.1925  0.693
2010 Ruggiero A, Villa CH, Holland JP, Sprinkle SR, May C, Lewis JS, Scheinberg DA, McDevitt MR. Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes. International Journal of Nanomedicine. 5: 783-802. PMID 21042424 DOI: 10.2147/Ijn.S13300  0.661
2010 Holland JP, Divilov V, Bander NH, Smith-Jones PM, Larson SM, Lewis JS. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1293-300. PMID 20660376 DOI: 10.2967/Jnumed.110.076174  0.6
2010 Ruggiero A, Holland JP, Lewis JS, Grimm J. Cerenkov luminescence imaging of medical isotopes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1123-30. PMID 20554722 DOI: 10.2967/Jnumed.110.076521  0.631
2010 Lebedev AY, Holland JP, Lewis JS. Clickable bifunctional radiometal chelates for peptide labeling. Chemical Communications (Cambridge, England). 46: 1706-8. PMID 20177623 DOI: 10.1039/B924784J  0.558
2010 Holland JP, Williamson MJ, Lewis JS. Unconventional nuclides for radiopharmaceuticals. Molecular Imaging. 9: 1-20. PMID 20128994 DOI: 10.2310/7290.2010.00008  0.61
2010 Holland JP, Caldas-Lopes E, Divilov V, Longo VA, Taldone T, Zatorska D, Chiosis G, Lewis JS. Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab. Plos One. 5: e8859. PMID 20111600 DOI: 10.1371/Journal.Pone.0008859  0.599
2010 Bonnitcha PD, Bayly SR, Theobald MB, Betts HM, Lewis JS, Dilworth JR. Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia. Journal of Inorganic Biochemistry. 104: 126-35. PMID 19932509 DOI: 10.1016/J.Jinorgbio.2009.10.009  0.574
2010 Heneweer C, Holland J, Divilov V, Carlin S, Lewis J. Quantifizierung von EPR-Effekten 89Zr-Albumin in drei Prostatakarzinommodellen in vivo RöFo - Fortschritte Auf Dem Gebiet Der RöNtgenstrahlen Und Der Bildgebenden Verfahren. 182. DOI: 10.1055/s-0030-1268308  0.532
2010 Holland JP, Lewis JS. 89Zr-chemistry in the design of novel radiotracers for immunoPET Nuclear Medicine and Biology. 37: 690. DOI: 10.1016/J.Nucmedbio.2010.04.068  0.554
2009 Holland JP, Ferdani R, Anderson CJ, Lewis JS. Copper-64 Radiopharmaceuticals for Oncologic Imaging. Pet Clinics. 4: 49-67. PMID 27156895 DOI: 10.1016/J.Cpet.2009.04.013  0.63
2009 Holland JP, Sheh Y, Lewis JS. Standardized methods for the production of high specific-activity zirconium-89. Nuclear Medicine and Biology. 36: 729-39. PMID 19720285 DOI: 10.1016/J.Nucmedbio.2009.05.007  0.641
2009 Wei L, Zhang X, Gallazzi F, Miao Y, Jin X, Brechbiel MW, Xu H, Clifford T, Welch MJ, Lewis JS, Quinn TP. Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH. Nuclear Medicine and Biology. 36: 345-54. PMID 19423001 DOI: 10.1016/J.Nucmedbio.2009.01.007  0.352
2009 V?vere AL, Biddlecombe GB, Spees WM, Garbow JR, Wijesinghe D, Andreev OA, Engelman DM, Reshetnyak YK, Lewis JS. A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Research. 69: 4510-6. PMID 19417132 DOI: 10.1158/0008-5472.Can-08-3781  0.367
2009 Dunphy MP, Lewis JS. Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 106S-21S. PMID 19380404 DOI: 10.2967/Jnumed.108.057281  0.383
2009 Wei L, Ye Y, Wadas TJ, Lewis JS, Welch MJ, Achilefu S, Anderson CJ. (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. Nuclear Medicine and Biology. 36: 277-85. PMID 19324273 DOI: 10.1016/J.Nucmedbio.2008.12.008  0.329
2009 Schneider DW, Heitner T, Alicke B, Light DR, McLean K, Satozawa N, Parry G, Yoo J, Lewis JS, Parry R. In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 435-43. PMID 19223400 DOI: 10.2967/Jnumed.108.055608  0.388
2009 Choi JC, Hausner SH, Gagnon MKJ, Kukis DL, Holland JP, Lewis JS, Lin C, Johnson MD, Sutcliffe JL. Abstract A227: Positron emission tomographic (PET) imaging of activated matriptase, a marker for cancer progression Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A227  0.673
2009 Holland JP, Caldas‐Lopes E, Divilov V, Longo VA, Taldone T, Zatorska D, Chiosis G, Lewis JS. Abstract A226: ImmunoPET with 89Zr‐DFO‐trastuzumab: Monitoring the pharmacodynamic effects on HER2/neu expression by Hsp90 inhibition in vivo Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A226  0.627
2009 Holland JP, Jones MW, Bonnitcha PD, Lewis JS, Dilworth JR. Functionalised copper-64 complexes as precursors of potential PET imaging agents for neurodegenerative disorders New Journal of Chemistry. 33: 1845-1852. DOI: 10.1039/B902895A  0.692
2009 Holland JP, Ferdani R, Anderson CJ, Lewis JS. Copper-64 Radiopharmaceuticals for Oncologic Imaging Pet Clinics. 4: 49-67. DOI: 10.1016/j.cpet.2009.04.013  0.577
2008 Dietz DW, Dehdashti F, Grigsby PW, Malyapa RS, Myerson RJ, Picus J, Ritter J, Lewis JS, Welch MJ, Siegel BA. Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study. Diseases of the Colon and Rectum. 51: 1641-8. PMID 18682881 DOI: 10.1007/S10350-008-9420-3  0.363
2008 Dence CS, Ponde DE, Welch MJ, Lewis JS. Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer. Nuclear Medicine and Biology. 35: 713-20. PMID 18678357 DOI: 10.1016/J.Nucmedbio.2008.06.001  0.356
2008 Lewis JS, Laforest R, Dehdashti F, Grigsby PW, Welch MJ, Siegel BA. An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1177-82. PMID 18552145 DOI: 10.2967/Jnumed.108.051326  0.391
2008 Bonnitcha PD, Vāvere AL, Lewis JS, Dilworth JR. In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia. Journal of Medicinal Chemistry. 51: 2985-91. PMID 18416544 DOI: 10.1021/Jm800031X  0.586
2008 Vāvere AL, Lewis JS. Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines. Nuclear Medicine and Biology. 35: 273-9. PMID 18355682 DOI: 10.1016/J.Nucmedbio.2007.11.012  0.363
2008 Vāvere AL, Kridel SJ, Wheeler FB, Lewis JS. 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 327-34. PMID 18199615 DOI: 10.2967/Jnumed.107.046672  0.329
2008 Dehdashti F, Grigsby PW, Lewis JS, Laforest R, Siegel BA, Welch MJ. Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 201-5. PMID 18199612 DOI: 10.2967/Jnumed.107.048520  0.402
2008 Lu W, Li H, Lewis J, Thorstad W, Low D, Laforest R, Nussenbaum B, Zhu J, Parikh P, Wu B, Biehl K. SU-GG-J-03: 3D Pathology Validation for Head-And-Neck Tumor Segmentation in PET/CT/MRI Images Medical Physics. 35: 2679-2679. DOI: 10.1118/1.2961560  0.389
2007 Lewis JS, Anderson CJ. Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy. Methods in Molecular Biology (Clifton, N.J.). 386: 227-40. PMID 18604948 DOI: 10.1007/978-1-59745-430-8_8  0.398
2007 Alidori S, Gioia Lobbia G, Papini G, Pellei M, Porchia M, Refosco F, Tisato F, Lewis JS, Santini C. Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 13: 307-15. PMID 18043951 DOI: 10.1007/S00775-007-0322-Y  0.361
2007 Wei L, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Vāvere AL, Lewis JS. Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma. Nuclear Medicine and Biology. 34: 945-53. PMID 17998097 DOI: 10.1016/J.Nucmedbio.2007.07.003  0.444
2007 Vāvere AL, Lewis JS. Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia. Dalton Transactions (Cambridge, England : 2003). 4893-902. PMID 17992274 DOI: 10.1039/B705989B  0.338
2007 Biddlecombe GB, Rogers BE, de Visser M, Parry JJ, de Jong M, Erion JL, Lewis JS. Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14). Bioconjugate Chemistry. 18: 724-30. PMID 17378600 DOI: 10.1021/Bc060281L  0.435
2007 Jost SC, Wanebo JE, Song SK, Chicoine MR, Rich KM, Woolsey TA, Lewis JS, Mach RH, Xu J, Garbow JR. In vivo imaging in a murine model of glioblastoma. Neurosurgery. 60: 360-70; discussion 3. PMID 17290188 DOI: 10.1227/01.Neu.0000249264.80579.37  0.397
2007 Padhani AR, Krohn KA, Lewis JS, Alber M. Imaging oxygenation of human tumours. European Radiology. 17: 861-72. PMID 17043737 DOI: 10.1007/S00330-006-0431-Y  0.366
2006 Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, et al. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. International Journal of Radiation Biology. 82: 699-757. PMID 17118889 DOI: 10.1080/09553000601002324  0.377
2006 Clifford T, Boswell CA, Biddlecombe GB, Lewis JS, Brechbiel MW. Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide. Journal of Medicinal Chemistry. 49: 4297-304. PMID 16821789 DOI: 10.1021/Jm060317V  0.367
2006 Ruangma A, Bai B, Lewis JS, Sun X, Welch MJ, Leahy R, Laforest R. Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides. Nuclear Medicine and Biology. 33: 217-26. PMID 16546676 DOI: 10.1016/J.Nucmedbio.2005.11.001  0.364
2005 Laforest R, Sharp TL, Engelbach JA, Fettig NM, Herrero P, Kim J, Lewis JS, Rowland DJ, Tai YC, Welch MJ. Measurement of input functions in rodents: challenges and solutions. Nuclear Medicine and Biology. 32: 679-85. PMID 16243642 DOI: 10.1016/J.Nucmedbio.2005.06.012  0.306
2005 Parry R, Schneider D, Hudson D, Parkes D, Xuan JA, Newton A, Toy P, Lin R, Harkins R, Alicke B, Biroc S, Kretschmer PJ, Halks-Miller M, Klocker H, Zhu Y, ... Lewis JS, et al. Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer. Cancer Research. 65: 8397-405. PMID 16166318 DOI: 10.1158/0008-5472.Can-05-1203  0.381
2005 McQuade P, Rowland DJ, Lewis JS, Welch MJ. Positron-emitting isotopes produced on biomedical cyclotrons. Current Medicinal Chemistry. 12: 807-18. PMID 15853713 DOI: 10.2174/0929867053507397  0.324
2005 McQuade P, Miao Y, Yoo J, Quinn TP, Welch MJ, Lewis JS. Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH. Journal of Medicinal Chemistry. 48: 2985-92. PMID 15828837 DOI: 10.1021/Jm0490282  0.427
2005 O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, Burnazi E, Finn RD, Burgman P, Ruan S, Lewis JS, Welch MJ, Ling CC, Humm JL. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. International Journal of Radiation Oncology, Biology, Physics. 61: 1493-502. PMID 15817355 DOI: 10.1016/J.Ijrobp.2004.12.057  0.405
2005 Laforest R, Dehdashti F, Lewis JS, Schwarz SW. Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET. European Journal of Nuclear Medicine and Molecular Imaging. 32: 764-70. PMID 15785955 DOI: 10.1007/S00259-004-1756-X  0.341
2005 McQuade P, Martin KE, Castle TC, Went MJ, Blower PJ, Welch MJ, Lewis JS. Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents. Nuclear Medicine and Biology. 32: 147-56. PMID 15721760 DOI: 10.1016/J.Nucmedbio.2004.10.004  0.37
2004 Obata A, Yoshimoto M, Kasamatsu S, Naiki H, Takamatsu S, Kashikura K, Furukawa T, Lewis JS, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG. Nuclear Medicine and Biology. 30: 529-34. PMID 12831991 DOI: 10.1016/S0969-8051(03)00047-7  0.381
2004 Schwarz J, Kim E, Malyapa R, Grigsby P, Lewis J, Higashikubo R, Horikoshi N, Huettner P, Dehdashti F, Mintun M, Siegel B, Welch M. Oncologic imaging of tumor hypoxia by Cu-ATSM and correlating findings on Cu-ATSM PET scans to cellular markers that may predict for radiation response International Journal of Radiation Oncology*Biology*Physics. 60: S305-S306. DOI: 10.1016/J.Ijrobp.2004.07.109  0.37
2003 Mathias CJ, Lewis MR, Reichert DE, Laforest R, Sharp TL, Lewis JS, Yang ZF, Waters DJ, Snyder PW, Low PS, Welch MJ, Green MA. Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nuclear Medicine and Biology. 30: 725-31. PMID 14499330 DOI: 10.1016/S0969-8051(03)00080-5  0.332
2003 Scappaticci FA, Contreras A, Boswell CA, Lewis JS, Nolan G. Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice. Vaccine. 21: 2667-77. PMID 12744904 DOI: 10.1016/S0264-410X(02)00693-X  0.393
2003 Dehdashti F, Mintun MA, Lewis JS, Bradley J, Govindan R, Laforest R, Welch MJ, Siegel BA. In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM. European Journal of Nuclear Medicine and Molecular Imaging. 30: 844-50. PMID 12692685 DOI: 10.1007/S00259-003-1130-4  0.388
2003 Dehdashti F, Grigsby PW, Mintun MA, Lewis JS, Siegel BA, Welch MJ. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. International Journal of Radiation Oncology, Biology, Physics. 55: 1233-8. PMID 12654432 DOI: 10.1016/S0360-3016(02)04477-2  0.384
2003 Rowland DJ, Lewis JS, Welch MJ. Molecular imaging: the application of small animal positron emission tomography. Journal of Cellular Biochemistry. Supplement. 39: 110-5. PMID 12552610 DOI: 10.1002/Jcb.10417  0.388
2002 Lewis JS, Achilefu S, Garbow JR, Laforest R, Welch MJ. Small animal imaging: Current technology and perspectives for oncological imaging European Journal of Cancer. 38: 2173-2188. PMID 12387842 DOI: 10.1016/S0959-8049(02)00394-5  0.344
2002 Li WP, Lewis JS, Kim J, Bugaj JE, Johnson MA, Erion JL, Anderson CJ. DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjugate Chemistry. 13: 721-8. PMID 12121126 DOI: 10.1021/Bc015590K  0.38
2002 Dearling JL, Lewis JS, Mullen GE, Welch MJ, Blower PJ. Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 7: 249-59. PMID 11935349 DOI: 10.1007/S007750100291  0.359
2002 Chao K, Bosch WR, Malyapa R, Lewis JS, Dehdashti F, Welch MJ. Evolution of tumor hypoxia during radiotherapy predicts treatment response: implication of hypoxic imaging-guided IMRT International Journal of Radiation Oncology Biology Physics. 54: 72-73. DOI: 10.1016/S0360-3016(02)03182-6  0.334
2001 Obata A, Yoshimi E, Waki A, Lewis JS, Oyama N, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent Cu-diacetyl-bis( N 4 -methylthiosemicarbazone) (Cu-ATSM) in tumor cells Annals of Nuclear Medicine. 15: 499-504. PMID 11831397 DOI: 10.1007/Bf02988502  0.344
2001 Lewis JS, Wang M, Laforest R, Wang F, Erion JL, Bugaj JE, Srinivasan A, Anderson CJ. Toxicity and dosimetry of 177Lu-DOTA-Y3-octreotate in a rat model International Journal of Cancer. 94: 873-877. PMID 11745491 DOI: 10.1002/Ijc.1540  0.318
2001 Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 49: 1171-82. PMID 11240261 DOI: 10.1016/S0360-3016(00)01433-4  0.398
2001 Lewis JS, Laforest R, Buettner TL, Song SK, Fujibayashi Y, Connett JM, Welch MJ. Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy Proceedings of the National Academy of Sciences of the United States of America. 98: 1206-1211. PMID 11158618 DOI: 10.1073/Pnas.98.3.1206  0.345
2001 Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ. A prospective study on tumor hypoxia kinetics to implement hypoxic imaging-guided IMRT International Journal of Radiation Oncology Biology Physics. 51: 83. DOI: 10.1016/S0360-3016(01)01977-0  0.363
2001 Lewis JS, Connett JM, Garbow JR, Buettner TL, Fujibayashi Y, Fleshman JW, Welch MJ. 64Cu-PTSM as an inhibitor of tumor recurrence Journal of Labelled Compounds and Radiopharmaceuticals. 44: S87-S89. DOI: 10.1002/Jlcr.2580440130  0.308
2000 Lewis JS, Laforest R, Lewis MR, Anderson CJ. Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model. Cancer Biotherapy & Radiopharmaceuticals. 15: 593-604. PMID 11190491 DOI: 10.1089/Cbr.2000.15.593  0.325
2000 Lewis JS, Dearling JL, Sosabowski JK, Zweit J, Carnochan P, Kelland LR, Coley HM, Blower PJ. Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET. European Journal of Nuclear Medicine. 27: 638-46. PMID 10901449 DOI: 10.1007/S002590050557  0.378
2000 Anderson CJ, Lewis JS. Radiopharmaceuticals for targeted radiotherapy of cancer Expert Opinion On Therapeutic Patents. 10: 1057-1069. DOI: 10.1517/13543776.10.7.1057  0.349
1999 McCarthy DW, Bass LA, Cutler PD, Shefer RE, Klinkowstein RE, Herrero P, Lewis JS, Cutler CS, Anderson CJ, Welch MJ. High purity production and potential applications of copper-60 and copper-61. Nuclear Medicine and Biology. 26: 351-8. PMID 10382836 DOI: 10.1016/S0969-8051(98)00113-9  0.32
1999 Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake. Nuclear Medicine and Biology. 26: 267-73. PMID 10363797 DOI: 10.1016/S0969-8051(98)00105-X  0.402
1999 Lewis JS, Lewis MR, Srinivasan A, Schmidt MA, Wang J, Anderson CJ. Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy. Journal of Medicinal Chemistry. 42: 1341-7. PMID 10212119 DOI: 10.1021/Jm980602H  0.364
1999 Reichert DE, Lewis JS, Anderson CJ. Metal complexes as diagnostic tools Coordination Chemistry Reviews. 184: 3-66. DOI: 10.1016/S0010-8545(98)00207-0  0.373
1998 Dearling JL, Lewis JS, Mullen GE, Rae MT, Zweit J, Blower PJ. Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro. European Journal of Nuclear Medicine. 25: 788-92. PMID 9662602 DOI: 10.1007/S002590050283  0.321
1996 Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine Nuclear Medicine and Biology. 23: 957-980. PMID 9004284 DOI: 10.1016/S0969-8051(96)00130-8  0.359
1996 Lewis JS, Zweit J, Dearling JLJ, Rooney BC, Blower PJ. Copper(I) bis(diphosphine) complexes as a basis for radiopharmaceuticals for positron emission tomography and targeted radiotherapy Chemical Communications. 1093-1094. DOI: 10.1039/Cc9960001093  0.382
1996 Dilworth JR, Hutson AJ, Lewis JS, Miller JR, Zheng Y, Chen Q, Zubieta J. Complexes of potentially tri- and tetra-dentate phosphinothiol ligands with Mo, W, Re, Fe, Ru, Os, Rh, Ir and Ni Journal of the Chemical Society - Dalton Transactions. 1093-1104.  0.403
1995 Dilworth JR, Lewis JS, Miller JR, Zheng Y. Rhenium complex of a triply deprotonated chelated thiosemicarbazide and its conversion to a nitride complex via a hydrazide intermediate. Crystal structure of [ReCl2(NH)(NHNH2)(PPh3)2] Journal of the Chemical Society, Dalton Transactions. 1357-1361. DOI: 10.1039/Dt9950001357  0.466
1993 Dilworth JR, Lewis JS, Miller JR, Zheng Y. The preparation of rhenium(V) oxo and imido complexes with Et2NCSNHCOPh and Et2NCSBC(NH)Ph. The x-ray crystal structure of [ReOCl(PhCONCSNEt2)2] Polyhedron. 12: 221-225. DOI: 10.1016/S0277-5387(00)81630-7  0.468
Low-probability matches (unlikely to be authored by this person)
2016 Ackermann U, Lewis JS, Young K, Morris MJ, Weickhardt A, Davis ID, Scott AM. Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab module. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 27378195 DOI: 10.1002/Jlcr.3417  0.299
2024 Yeh R, O'Donoghue JA, Jayaprakasam VS, Mauguen A, Min R, Park S, Brockway JP, Bromberg JF, Zhi WI, Robson ME, Sanford R, Modi S, Agnew BJ, Lyashchenko SK, Lewis JS, et al. First-in-Human Evaluation of Site-Specifically Labeled Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38272704 DOI: 10.2967/jnumed.123.266392  0.298
2019 Reidy-Lagunes D, Pandit-Taskar N, O'Donoghue JA, Krebs S, Staton KD, Lyashchenko SK, Lewis JS, Raj N, Gonen M, Lohrmann C, Bodei L, Weber WA. Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177 Lu-Satoreotide Tetraxetan. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31439583 DOI: 10.1158/1078-0432.Ccr-19-1026  0.297
2005 Obata A, Kasamatsu S, Lewis JS, Furukawa T, Takamatsu S, Toyohara J, Asai T, Welch MJ, Adams SG, Saji H, Yonekura Y, Fujibayashi Y. Basic characterization of 64Cu-ATSM as a radiotherapy agent. Nuclear Medicine and Biology. 32: 21-8. PMID 15691658 DOI: 10.1016/J.Nucmedbio.2004.08.012  0.297
2009 Zhou D, Zhou H, Jenks CC, Lewis JS, Katzenellenbogen JA, Welch MJ. Bromination from the macroscopic level to the tracer radiochemical level: (76)Br radiolabeling of aromatic compounds via electrophilic substitution. Bioconjugate Chemistry. 20: 808-16. PMID 19260733 DOI: 10.1021/Bc800313C  0.297
2017 Kramer K, Kushner BH, Modak S, Pandit-Taskar N, Tomlinson U, Wolden SL, Zanzonico P, John HL, Haque S, Souweidane MM, Greenfield J, Basu EM, Roberts SS, Carrasquillo JA, Lewis JS, et al. A curative approach to central nervous system metastases of neuroblastoma. Journal of Clinical Oncology. 35: 10545-10545. DOI: 10.1200/Jco.2017.35.15_Suppl.10545  0.296
2018 Thorek DL, Ku AT, Mitsiades N, Veach D, Watson PA, Mehta D, Strand SE, Sharma SK, Lewis JS, Abou DS, Lilja HG, Larson SM, McDevitt MR, Ulmert D. Harnessing Androgen-Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30254080 DOI: 10.1158/1078-0432.Ccr-18-1521  0.295
2023 Arroyo A, Lyashchenko SK, Lewis JS. Methods for the Production of Radiolabeled Bioagents for ImmunoPET. Methods in Molecular Biology (Clifton, N.J.). 2729: 117-142. PMID 38006494 DOI: 10.1007/978-1-0716-3499-8_8  0.295
2005 Burgman P, O'Donoghue JA, Lewis JS, Welch MJ, Humm JL, Ling CC. Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM. Nuclear Medicine and Biology. 32: 623-30. PMID 16026709 DOI: 10.1016/J.Nucmedbio.2005.05.003  0.292
2016 Rodina A, Wang T, Yan P, Gomes ED, Dunphy MP, Pillarsetty N, Koren J, Gerecitano JF, Taldone T, Zong H, Caldas-Lopes E, Alpaugh M, Corben A, Riolo M, Beattie B, ... ... Lewis JS, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. PMID 27706135 DOI: 10.1038/Nature19807  0.291
2019 Escorcia F, Houghton J, Abdel-Atti D, Pereira P, Cho A, Lewis J. Met-Targeted Radioligand Therapy in KRAS-pathway Activated Pancreatic Cancer Resistant to Met Kinase Inhibitors International Journal of Radiation Oncology*Biology*Physics. 105: E235. DOI: 10.1016/J.Ijrobp.2019.06.2007  0.288
2013 Nemunaitis J, McArthur H, Hudis C, Reed T, Broder S, Lebel F, Barrett J, Lewis J, Norton L. Abstract P5-02-01: Regulated intratumoral expression of IL-12 in combination with cytotoxic agents as a strategy for the treatment of metastatic breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-02-01  0.287
2023 Ahad A, Aftab F, Michel A, Lewis JS, Contel M. Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers. Rsc Medicinal Chemistry. 15: 139-150. PMID 38283233 DOI: 10.1039/d3md00334e  0.286
2009 Papini G, Alidori S, Lewis JS, Reichert DE, Pellei M, Gioia Lobbia G, Biddlecombe GB, Anderson CJ, Santini C. Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes. Dalton Transactions (Cambridge, England : 2003). 177-84. PMID 19081987 DOI: 10.1039/B808831D  0.286
2018 Kramer K, Kushner B, Modak S, Taskar NP, Tomlinson U, Donzelli M, Wolden S, Zanzonico P, Humm J, Haque S, Souweidane M, Greenfield J, Basu E, Roberts S, Carrasquillo J, ... Lewis J, et al. IMMU-05. SAFETY AND EFFICACY OF INTRAVENTRICULAR 131I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 Neuro-Oncology. 20: i99-i99. DOI: 10.1093/Neuonc/Noy059.321  0.286
1998 Dearling JLJ, Lewis JS, McCarthy DW, Welch MJ, Blower PJ. Redox-active metal complexes for imaging hypoxic tissues: structure–activity relationships in copper(II) bis(thiosemicarbazone) complexes Chemical Communications. 2531-2532. DOI: 10.1039/A805957H  0.283
2024 Tendler S, Dunphy MP, Agee M, O'Donoghue J, Aly RG, Choudhury NJ, Kesner A, Kirov A, Mauguen A, Baine MK, Schoder H, Weber WA, Rekhtman N, Lyashchenko SK, Bodei L, ... ... Lewis JS, et al. First-in-human imaging with [Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. Medrxiv : the Preprint Server For Health Sciences. PMID 38260492 DOI: 10.1101/2024.01.10.24301109  0.281
2022 Lumish MA, Maron SB, Paroder V, Chou JF, Capanu M, Philemond S, O'Donoghue JA, Schöder H, Lewis JS, Lyaschenko SK, Pandit-Taskar N, Janjigian YY. Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using Zr-trastuzumab PET: a pilot study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 36418168 DOI: 10.2967/jnumed.122.264470  0.281
2006 Silva MJ, Uthgenannt BA, Rutlin JR, Wohl GR, Lewis JS, Welch MJ. In vivo skeletal imaging of 18F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna. Bone. 39: 229-36. PMID 16533624 DOI: 10.1016/J.Bone.2006.01.149  0.28
2005 Viehl CT, Becker-Hapak M, Lewis JS, Tanaka Y, Liyanage UK, Linehan DC, Eberlein TJ, Goedegebuure PS. A tat fusion protein-based tumor vaccine for breast cancer. Annals of Surgical Oncology. 12: 517-25. PMID 15889213 DOI: 10.1245/Aso.2005.06.028  0.279
2020 Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, Gambhir SS, Hricak H, Weissleder R. Radiotheranostics: a roadmap for future development. The Lancet. Oncology. 21: e146-e156. PMID 32135118 DOI: 10.1016/S1470-2045(19)30821-6  0.278
2021 Bauer DD, Álvarez NH, Hernández-Gil J, Lewis JS. Recent advances in Radiometals for Combined Imaging and Therapy. Chemmedchem. PMID 33792195 DOI: 10.1002/cmdc.202100135  0.274
2019 Carter LM, Crawford TM, Sato T, Furuta T, Choi C, Kim CH, Brown JL, Bolch WE, Zanzonico PB, Lewis JS. PARaDIM - A PHITS-based Monte Carlo tool for internal dosimetry with tetrahedral mesh computational phantoms. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31201251 DOI: 10.2967/Jnumed.119.229013  0.273
2018 Kramer K, Taskar NP, Humm J, Zanzonico P, Donzelli M, Haque S, Khakoo Y, Lewis J, Cheung N. EPEN-04. RECURRENT EPENDYMOMA: ROLE OF INTRAVENTRICULAR TARGETED RADIOIMMUNOTHERAPY Neuro-Oncology. 20: i74-i74. DOI: 10.1093/Neuonc/Noy059.205  0.272
2023 Ahad A, K Saeed H, Del Solar V, López-Hernández JE, Michel A, Mathew J, Lewis JS, Contel M. Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model. Acs Pharmacology & Translational Science. 6: 1972-1986. PMID 38093840 DOI: 10.1021/acsptsci.3c00270  0.272
2014 Andersen KF, Divilov V, Sevak K, Koziorowski J, Lewis JS, Pillarsetty N. Influence of free fatty acids on glucose uptake in prostate cancer cells. Nuclear Medicine and Biology. 41: 254-8. PMID 24440212 DOI: 10.1016/J.Nucmedbio.2013.12.005  0.272
2023 Bauer D, Carter LM, Atmane MI, De Gregorio R, Michel A, Kaminsky S, Monette S, Li M, Schultz MK, Lewis JS. Pb-Pretargeted Theranostics for Pancreatic Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37945380 DOI: 10.2967/jnumed.123.266388  0.271
2018 Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M, Turner RS, Lewis JS, Cheung NV, Larson SM, Dunkel IJ. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. The Lancet. Oncology. PMID 29914796 DOI: 10.1016/S1470-2045(18)30322-X  0.271
2003 Aft RL, Lewis JS, Zhang F, Kim J, Welch MJ. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose. Cancer Research. 63: 5496-504. PMID 14500386  0.271
2022 Korsen JA, Kalidindi TM, Khitrov S, Samuels ZV, Chakraborty G, Gutierrez JA, Poirier JT, Rudin CM, Chen Y, Morris MJ, Pillarsetty N, Lewis JS. Molecular imaging of Neuroendocrine Prostate Cancer by targeting Delta-like Ligand 3. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35058323 DOI: 10.2967/jnumed.121.263221  0.267
2014 Huang CH, Lujambio A, Zuber J, Tschaharganeh DF, Doran MG, Evans MJ, Kitzing T, Zhu N, de Stanchina E, Sawyers CL, Armstrong SA, Lewis JS, Sherr CJ, Lowe SW. CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. Genes & Development. 28: 1800-14. PMID 25128497 DOI: 10.1101/Gad.244368.114  0.266
2005 Yoo J, Tang L, Perkins TA, Rowland DJ, Laforest R, Lewis JS, Welch MJ. Preparation of high specific activity (86)Y using a small biomedical cyclotron. Nuclear Medicine and Biology. 32: 891-7. PMID 16253815 DOI: 10.1016/J.Nucmedbio.2005.06.007  0.266
2007 Kuperman DI, Nussenbaum B, Thorstad W, Haughey B, Lewis J, Adkins D. Retrospective analysis of the addition of cetuximab to induction chemotherapy (IC) with docetaxel, cisplatin, and 5-fluorouracil (TPF-C) for locally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) Journal of Clinical Oncology. 25: 6072-6072. DOI: 10.1200/Jco.2007.25.18_Suppl.6072  0.265
2010 Anderson H, Pillarsetty N, Cantorias M, Lewis JS. Improved synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU). Nuclear Medicine and Biology. 37: 439-42. PMID 20447555 DOI: 10.1016/J.Nucmedbio.2010.01.003  0.265
2001 Li WP, Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. Copper-64/61 and iodine-125-labeled dota-DTYR1-octreotate: A new somatostatin analog for labeling with metals and halogens Journal of Labelled Compounds and Radiopharmaceuticals. 44: S948-S950. DOI: 10.1002/Jlcr.25804401333  0.263
2015 Kramer K, Pandit-Taskar N, Zanzonico P, Wolden SL, Humm JL, DeSelm C, Souweidane MM, Lewis JS, Cheung NK. Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy. Journal of Neuro-Oncology. 123: 245-9. PMID 25944385 DOI: 10.1007/S11060-015-1788-Z  0.262
2014 Hurwitz M, Rottmann J, Williams C, Dhou S, Wagar M, Mannarino E, Seco J, Lewis J. SU-E-J-228: Dose Accumulation Studies with a Dynamic Physical Anthropomorphic Phantom and An External Surrogate-Based Motion Model. Medical Physics. 41: 210. PMID 28037593 DOI: 10.1118/1.4888281  0.261
2022 Bodei L, Herrmann K, Schöder H, Scott AM, Lewis JS. Radiotheranostics in oncology: current challenges and emerging opportunities. Nature Reviews. Clinical Oncology. PMID 35725926 DOI: 10.1038/s41571-022-00652-y  0.261
2019 Sharma SK, Lyashchenko SK, Park HA, Pillarsetty N, Roux Y, Wu J, Poty S, Tully KM, Poirier JT, Lewis JS. A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals. Nuclear Medicine and Biology. 71: 32-38. PMID 31128476 DOI: 10.1016/J.Nucmedbio.2019.04.005  0.259
2023 Brown EL, Shmuel S, Mandleywala K, Panikar SS, Berry NK, Rao Y, Zidel A, Lewis JS, Pereira PMR. Immuno-PET Detects Antibody-Drug Potency on Coadministration with Statins. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37385676 DOI: 10.2967/jnumed.122.265172  0.258
2014 Chin R, Spencer CR, DeWees T, Haughey BH, Nussenbaum B, Wildes T, Michel L, Adkins D, Lewis JS, Dehdashti F, Siegel BA, Thorstad WL. Prognostic Significance of Metabolic Tumor Volume After Induction Chemotherapy in Squamous Cell Carcinoma of the Head and Neck International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1673  0.258
2014 Fernández-Tejada A, Chea EK, George C, Pillarsetty N, Gardner JR, Livingston PO, Ragupathi G, Lewis JS, Tan DS, Gin DY. Development of a minimal saponin vaccine adjuvant based on QS-21. Nature Chemistry. 6: 635-43. PMID 24950335 DOI: 10.1038/Nchem.1963  0.256
2008 Zhou D, Sharp TL, Fettig NM, Lee H, Lewis JS, Katzenellenbogen JA, Welch MJ. Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies. Nuclear Medicine and Biology. 35: 655-63. PMID 18678350 DOI: 10.1016/J.Nucmedbio.2008.05.001  0.256
2004 Herrero P, Kim J, Sharp T, Dence C, Lewis JS, Gropler RJ, Welch MJ. 1116-24 Assessment of myocardial perfusion and metabolism in normal and diabetic rats by microPET imaging Journal of the American College of Cardiology. 43: A25. DOI: 10.1016/S0735-1097(04)90103-9  0.255
2014 Williams C, Lewis J. SU-E-J-63: Estimating the Effects of Respiratory Motion On Dose Heterogeneity for ITV-Based Treatments. Medical Physics. 41: 169-170. PMID 28036769 DOI: 10.1118/1.4888115  0.254
2020 Brito A, Pereira PMR, Soares da Costa D, Reis RL, Ulijn RV, Lewis JS, Pires RA, Pashkuleva I. Inhibiting cancer metabolism by aromatic carbohydrate amphiphiles that act as antagonists of the glucose transporter GLUT1 Chemical Science. 11: 3737-3744. DOI: 10.1039/D0Sc00954G  0.254
2023 Herrero Alvarez N, Michel AL, Viray TD, Mayerhoefer ME, Lewis JS. Zr-DFO-Isatuximab for CD38-Targeted ImmunoPET Imaging of Multiple Myeloma and Lymphomas. Acs Omega. 8: 22486-22495. PMID 37396228 DOI: 10.1021/acsomega.3c00624  0.253
2017 Wyatt LC, Lewis JS, Andreev OA, Reshetnyak YK, Engelman DM. Applications of pHLIP Technology for Cancer Imaging and Therapy: (Trends in Biotechnology 35, 653-664, 2017). Trends in Biotechnology. PMID 29198980 DOI: 10.1016/J.Tibtech.2017.11.005  0.252
2013 Andersen KF, Divilov V, Koziorowski J, Pillarsetty N, Lewis JS. Antilipolytic drug boosts glucose metabolism in prostate cancer. Nuclear Medicine and Biology. 40: 524-8. PMID 23454248 DOI: 10.1016/J.Nucmedbio.2013.01.008  0.25
2018 Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. Alpha Emitters for Radiotherapy: Basic Radiochemistry to Clinical Studies - Part 2. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29496984 DOI: 10.2967/Jnumed.117.204651  0.25
1998 Lewis JS, Zweit J, Blower PJ. Effect of ligand and solvent on chloride ion coordination in anti-tumour copper(I) diphosphine complexes: Synthesis of [Cu(dppe)2]Cl and analogous complexes (dppe = 1,2-bis(diphenylphosphino)ethane) Polyhedron. 17: 513-517. DOI: 10.1016/S0277-5387(97)00343-4  0.248
2022 Korsen JA, Gutierrez JA, Tully KM, Carter LM, Samuels ZV, Khitrov S, Poirier JT, Rudin CM, Chen Y, Morris MJ, Bodei L, Pillarsetty N, Lewis JS. Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 119: e2203820119. PMID 35759660 DOI: 10.1073/pnas.2203820119  0.246
2021 Mason C, Gimblet GR, Lapi SE, Lewis JS. Novel Tracers and Radionuclides in PET Imaging. Radiologic Clinics of North America. 59: 887-918. PMID 34392925 DOI: 10.1016/j.rcl.2021.05.012  0.245
2007 Abad PC, Lewis J, Mian IS, Knowles DW, Sturgis J, Badve S, Xie J, Lelièvre SA. NuMA influences higher order chromatin organization in human mammary epithelium. Molecular Biology of the Cell. 18: 348-61. PMID 17108325 DOI: 10.1091/Mbc.E06-06-0551  0.244
2021 Volpe A, Pillarsetty NVK, Lewis JS, Ponomarev V. Applications of nuclear-based imaging in gene and cell therapy: probe considerations. Molecular Therapy Oncolytics. 20: 447-458. PMID 33718593 DOI: 10.1016/j.omto.2021.01.017  0.243
2011 Rivet EB, Mutch MG, Ritter JH, Khan AA, Lewis JS, Winslow E, Fleshman JW. Ex vivo sentinel lymph node mapping in laparoscopic resection of colon cancer. Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland. 13: 1249-55. PMID 21083799 DOI: 10.1111/J.1463-1318.2010.02450.X  0.241
2003 Welch MJ, Lewis JS. [Tc(CO)(3)](+) chemistry: a promising new concept for SPECT? Against. European Journal of Nuclear Medicine and Molecular Imaging. 30: 1302-4. PMID 12898205 DOI: 10.1007/S00259-003-1293-Z  0.241
2017 Kramer K, Pandit-Taskar N, Humm J, Zanzonico P, Haque S, Dunkel I, Wolden S, Donzelli M, Goldman D, Lewis J, Lyashchenko S, Khakoo Y, Carrasquillo J, Souweidane M, Greenfield J, et al. MEDU-04. A PHASE II STUDY OF RADIOIMMUNOTHERAPY WITH INTRAVENTRICULAR 131I-3F8 FOR MEDULLOBLASTOMA Neuro-Oncology. 19: iv38-iv38. DOI: 10.1093/Neuonc/Nox083.155  0.239
2021 Sharma SK, Suzuki M, Xu H, Korsen JA, Samuels Z, Guo H, Nemieboka B, Piersigilli A, Edwards KJ, Cheung NK, Lewis JS. Influence of Fc modifications and IgG subclass on biodistribution of humanized antibodies targeting L1CAM. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34353869 DOI: 10.2967/jnumed.121.262383  0.237
2013 Pickett JE, Nagakura K, Pasternak AR, Grinnell SG, Majumdar S, Lewis JS, Pasternak GW. Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin. Bioorganic & Medicinal Chemistry Letters. 23: 4347-50. PMID 23796454 DOI: 10.1016/J.Bmcl.2013.05.090  0.237
1971 Johnson BFG, Johnston RD, Lewis J, Williams IG. The chemistry of polynuclear compounds. Part XXIII. Some monomeric carboxylate derivatives of ruthenium carbonyl Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 689-691. DOI: 10.1039/J19710000689  0.237
2018 Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. Alpha Emitters for Radiotherapy: Basic Radiochemistry to Clinical Studies _ Part 1. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29545378 DOI: 10.2967/Jnumed.116.186338  0.236
2022 Pereira PMR, Mandleywala K, Monette S, Lumish M, Tully KM, Panikar SS, Cornejo M, Mauguen A, Ragupathi A, Keltee NC, Mattar M, Janjigian YY, Lewis JS. Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. Nature Communications. 13: 2526. PMID 35534471 DOI: 10.1038/s41467-022-30142-9  0.236
1997 Lewis JS, Heath SL, Powell AK, Zweit J, Blower PJ. Diphosphine bifunctional chelators for low-valent metal ions. Crystalstructures of the copper(I) complexes [CuClL12]and [CuL12][PF6][L1 = 2,3-bis(diphenylphosphino)maleicanhydride] Journal of the Chemical Society-Dalton Transactions. 855-862. DOI: 10.1039/A607203H  0.23
2002 Lewis JS, Connett JM, Garbow JR, Buettner TL, Fujibayashi Y, Fleshman JW, Welch MJ. Copper-64-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: Monitoring therapy response with microPET and magnetic resonance imaging Cancer Research. 62: 445-449. PMID 11809694  0.229
1969 Crooks GR, Johnson BFG, Lewis J, Williams IG, Gamlen G. Chemistry of polynuclear compounds. Part XVII. Some carboxylate complexes of ruthenium and osmium carbonyls Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 2761-2766. DOI: 10.1039/J19690002761  0.229
2023 Mc Larney BE, Kim M, Roberts S, Skubal M, Hsu HT, Ogirala A, Pratt EC, Pillarsetty NVK, Heller DA, Lewis JS, Grimm J. Ambient Light Resistant Shortwave Infrared Fluorescence Imaging for Preclinical Tumor Delineation via the pH Low-Insertion Peptide Conjugated to Indocyanine Green. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37620049 DOI: 10.2967/jnumed.123.265686  0.228
2022 Kramer K, Pandit-Taskar N, Kushner BH, Zanzonico P, Humm JL, Tomlinson U, Donzelli M, Wolden SL, Haque S, Dunkel I, Souweidane MM, Greenfield JP, Tickoo S, Lewis JS, Lyashchenko SK, et al. Phase 1 study of intraventricular I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies. Journal of Hematology & Oncology. 15: 165. PMID 36371226 DOI: 10.1186/s13045-022-01383-4  0.227
1989 Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: Pharmacokinetics and toxicity American Journal of Roentgenology. 152: 167-173. PMID 2783272 DOI: 10.2214/Ajr.152.1.167  0.227
2015 Khwaja SS, Zhao H, Spencer CR, Thorstad WL, Lewis JS, Wang X. Gene Expression Profiling Implicates the Tumor Suppressor miR-206 in HPV+ Oropharyngeal Squamous Cell Carcinoma Distant Recurrence International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1874  0.226
2020 Crawford T, Moshnikova A, Roles S, Weerakkody D, DuPont M, Carter LM, Shen J, Engelman DM, Lewis JS, Andreev OA, Reshetnyak YK. pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery. Scientific Reports. 10: 18356. PMID 33110131 DOI: 10.1038/s41598-020-75443-5  0.226
2021 Kalidindi TM, Lee SG, Jou K, Chakraborty G, Skafida M, Tagawa ST, Bander NH, Schoder H, Bodei L, Pandit-Taskar N, Lewis JS, Larson SM, Osborne JR, Pillarsetty NVK. A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33495926 DOI: 10.1007/s00259-020-05150-w  0.222
1970 Johnson BFG, Lewis J, Robinson PW. The chemistry of polynuclear compounds. Part XX. Reactivity of hexadecacarbonylhexarhodium Journal of the Chemical Society a: Inorganic, Physical, and Theoretical Chemistry. 1100-1103. DOI: 10.1039/J19700001100  0.221
2020 Volpe A, Nagle VL, Lewis JS, Ponomarev V. Predicting CAR-T cell immunotherapy success through immunoPET. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33328345 DOI: 10.1158/1078-0432.CCR-20-4297  0.221
2007 Gibson MC, Ciaglo LN, Southard MC, Takao S, Harrigan C, Lewis J, Filopei J, Lew M, Murphy SA, Buros J. Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: A review Journal of Thrombosis and Thrombolysis. 23: 135-145. PMID 17221332 DOI: 10.1007/S11239-006-9015-6  0.22
2019 Chow A, Schad S, Sharma SK, Budhu S, Gupta A, Pimentel C, Zhong H, Lewis JS, Poirier JT, Wolchok JD, Rudin CM, Merghoub T. Abstract 978: Tim-4+tissue-resident macrophages impair antitumor T-cell immunity Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-978  0.218
2013 Wang X, Hullings M, Arauz G, Bartido S, Lewis JS, Schöder H, Zanzonico P, Scher HI, Sadelain M, Riviere I. Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 72. PMID 28137105 DOI: 10.1200/jco.2013.31.6_suppl.72  0.216
1996 Dilworth JR, Hutson AJ, Lewis JS, Miller JR, Zheng Y, Chen Q, Zubieta J. Complexes of potentially tri- and tetra-dentate phosphinothiol ligands with Mo, W, Re, Fe, Ru, Os, Rh, Ir and Ni Journal of the Chemical Society-Dalton Transactions. 1093-1104. DOI: 10.1039/Dt9960001093  0.216
2023 Rao Y, Samuels Z, Carter LM, Monette S, Panikar SS, Pereira PMR, Lewis JS. Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers. Proceedings of the National Academy of Sciences of the United States of America. 120: e2220413120. PMID 36972439 DOI: 10.1073/pnas.2220413120  0.216
2015 Chin R, Spencer C, Hwang M, Pierro M, DeWees T, Gay H, Haughey B, Nussenbaum B, Adkins D, Wildes T, Michel L, Lewis J, Thorstad W. Superior Patient-Reported Quality of Life in Lateralized Tonsillar Carcinoma Treated With Unilateral Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 93: E299-E300. DOI: 10.1016/J.Ijrobp.2015.07.1302  0.216
2016 Houghton JL, Lyashchenko SK, Sawada R, Zanzonico P, Rudge S, Scholz WW, Maffuid P, Lewis JS. Abstract B44: Optimization and IND enabling investigations of MVT-2163 (89Zr-DFO-5B1) leading to First-in-Human readiness Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-B44  0.215
1970 Johnson BFG, Lewis J, Robinson PW. Mass spectra of inorganic molecules. Part VI. Some transition-metal hydride complexes Journal of the Chemical Society a: Inorganic, Physical, and Theoretical Chemistry. 1684-1687. DOI: 10.1039/J19700001684  0.214
2014 Chin R, Spencer C, Hwang M, Patel P, Gay H, Haughey B, Nussenbaum B, Adkins D, Lewis J, Thorstad W. 60 Versus 66 Gy for Adjuvant Radiation Therapy in High-Risk p16+ Oropharyngeal Carcinoma International Journal of Radiation Oncology*Biology*Physics. 88: 471-472. DOI: 10.1016/J.Ijrobp.2013.11.038  0.214
1969 Crooks GR, Johnson BFG, Lewis J, Williams IG. The chemistry of polynuclear compounds. Part XVI. Trinuclear thiol derivatives of dodecacarbonyl-triruthenium and -triosmium Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 797-799. DOI: 10.1039/J19690000797  0.212
2024 Cytryn SL, Pandit-Taskar N, Lumish MA, Maron SB, Gu P, Ku GY, Chou JF, Capanu M, Antoine A, Loegel D, Feder L, Philemond S, Lyashchenko SK, Lewis JS, Paroder V, et al. F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38514081 DOI: 10.2967/jnumed.123.267186  0.212
2004 Parry R, Schneider D, Biroc S, Halks-Miller M, Klocker H, Zhu Y, Larsen B, Lewis J, Dinter H, Parry G. 309 Therapeutic efficacy of the Y-90 labeled antibody 19G9, targeting a novel protein RG-1, expressed in metastatic prostate cancer European Journal of Cancer Supplements. 2: 94. DOI: 10.1016/S1359-6349(04)80317-3  0.211
2014 Hwang M, Spencer C, Patel P, Chin R, Gay H, Haughey B, Nussenbaum B, Adkins D, Lewis J, Thorstad W. Unilateral Radiation Therapy in Node-Positive Patients With Lateralized Tonsillar Carcinoma International Journal of Radiation Oncology*Biology*Physics. 88: 475. DOI: 10.1016/J.Ijrobp.2013.11.048  0.211
1968 Johnson BFG, Johnston RD, Lewis J, Robinson BH, Wilkinson G. Chemistry of polynuclear compounds. Part XII. Polynuclear hydrido-carbonyls of ruthenium Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 2856-2859. DOI: 10.1039/J19680002856  0.21
1970 Johnson BFG, Lewis J, Williams IG. The chemistry of polynuclear compounds. Part XIX. Products from the reaction of dodecacarbonyltriruthenium with di-n-butyl ether Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 901-903. DOI: 10.1039/J19700000901  0.209
1966 Lewis J, Manning AR, Miller JR. Chemistry of polynuclear compounds. Part V. The vibrational spectra of some phosphine derivatives of manganese carbonyl Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 845-854. DOI: 10.1039/J19660000845  0.209
1967 Edgar K, Johnson BFG, Lewis J, Williams IG, Wilson JM. Mass spectra of inorganic molecules. Part III. Some transition-metal carbonyl halide and thiol compounds Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 379-382. DOI: 10.1039/J19670000379  0.208
1968 Johnson BFG, Lewis J, Miller JR, Robinson BH, Robinson PW, Wojcicki A. C18O exchange studies on Mn(CO)5X systems (X = Cl or Br) Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 522-527. DOI: 10.1039/J19680000522  0.207
1968 Edgar K, Johnson BFG, Lewis J, Wild SB. Chemistry of polynuclear compounds. Part XI. Some Lewis-base adducts of mercuric halides and stannic chloride with substituted metal carbonyls of chromium, molybdenum, tungsten, and iron Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 2851-2855. DOI: 10.1039/J19680002851  0.205
1966 Lewis J, Manning AR, Miller JR, Wilson JM. Chemistry of polynuclear compounds. Part VII. The mass spectra of some polynuclear metal carbonyl complexes Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 1663-1670. DOI: 10.1039/J19660001663  0.205
1971 Johnson BFG, Johnston RD, Lewis J, Williams IG. Chemie Von Mehrkernigen Verbindungen 23. Mitt. Monomere Carboxylat-Derivate Von Rutheniumcarbonyl Cheminform. 2. DOI: 10.1002/Chin.197121062  0.205
1971 Bor G, Johnson BFG, Lewis J, Robinson PW. The infrared spectra of metal carbonyl compounds. Part IV. [ <sup>13</sup>C]-and [<sup>18</sup>O]-substitution in metal carbonyls Journal of the Chemical Society a: Inorganic, Physical, and Theoretical Chemistry. 696-698. DOI: 10.1039/J19710000696  0.205
2021 Chow A, Schad S, Green MD, Hellmann MD, Allaj V, Ceglia N, Zago G, Shah NS, Sharma SK, Mattar M, Chan J, Rizvi H, Zhong H, Liu C, Bykov Y, ... ... Lewis JS, et al. Tim-4 cavity-resident macrophages impair anti-tumor CD8 T cell immunity. Cancer Cell. PMID 34115989 DOI: 10.1016/j.ccell.2021.05.006  0.205
2021 Hricak H, Abdel-Wahab M, Atun R, Lette MM, Paez D, Brink JA, Donoso-Bach L, Frija G, Hierath M, Holmberg O, Khong PL, Lewis JS, McGinty G, Oyen WJG, Shulman LN, et al. Medical imaging and nuclear medicine: a Lancet Oncology Commission. The Lancet. Oncology. PMID 33676609 DOI: 10.1016/S1470-2045(20)30751-8  0.205
2012 Spencer C, Haughey B, Nussenbaum B, Adkins D, Wildes T, Lewis JS, Thorstad WL. Limiting High Level 2 and Contralateral Retropharyngeal Lymph Node (RPN) Treatment in Selected Patients With Head-and-Neck Squamous Cell Carcinoma (HNSCC) International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.061  0.204
1969 Johnson BFG, Lewis J, Robinson PW, Miller JR. The infrared spectra of metal carbonyl compounds. Part III. Exchange studies on tetracarbonylrhodium complexes of the type Rh2(CO) 4X2 (X = Cl, Br, I, SEt, or SPh) Journal of the Chemical Society a: Inorganic, Physical, and Theoretical Chemistry. 2693-2695. DOI: 10.1039/J19690002693  0.204
2010 Gay H, Spencer C, Lewis J, Liu E, El Naqa I, Adkins D, Deasy J, Nussenbaum B, Haughey B, Thorstad W. Outcomes of p16 Positive Oropharyngeal Squamous Cell Carcinoma Treated with Postoperative Adjuvant IMRT +/- Chemotherapy: A Retrospective Analysis International Journal of Radiation Oncology*Biology*Physics. 78: S63-S64. DOI: 10.1016/J.Ijrobp.2010.07.180  0.203
1968 Edgar K, Lewis J, Manning AR, Miller JR. The C–O binary combination spectra of some pentacarbonyl metal complexes Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 1217-1221. DOI: 10.1039/J19680001217  0.203
2019 Pillarsetty N, Jhaveri K, Taldone T, Caldas-Lopes E, Punzalan B, Joshi S, Bolaender A, Uddin MM, Rodina A, Yan P, Ku A, Ku T, Shah SK, Lyashchenko S, Burnazi E, ... ... Lewis JS, et al. Paradigms for Precision Medicine in Epichaperome Cancer Therapy. Cancer Cell. PMID 31668946 DOI: 10.1016/J.Ccell.2019.09.007  0.202
2006 Kim J, Herrero P, Sharp T, Laforest R, Rowland DJ, Tai YC, Lewis JS, Welch MJ. Minimally invasive method of determining blood input function from PET images in rodents. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 330-6. PMID 16455640  0.197
1969 Johnson BFG, Johnston RD, Lewis J. Chemistry of polynuclear compounds. Part XV. Halogenocarbonylruthenium compounds Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 792-797. DOI: 10.1039/J19690000792  0.197
1971 Bor G, Johnson BFG, Lewis J, Robinson PW. Ir-Spektren Von Metallcarbonylverbindungen 4. Mitt. Kohlenstoff-13- Und Sauerstoff-18-Substitution In Metallcarbonylen Cheminform. 2. DOI: 10.1002/Chin.197121050  0.197
1968 Johnson BFG, Lewis J, Robinson PW, Miller JR. The infrared spectra of metal carbonyl compounds. Part II. C18O exchange studies on cis-Fe(CO)4I2 Journal of the Chemical Society a: Inorganic, Physical, Theoretical. 1043-1048. DOI: 10.1039/J19680001043  0.195
2019 Phelps ME, Lewis JS. A Conversation Between Michael Phelps and Jason Lewis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 60: 439-442. PMID 30936253 DOI: 10.2967/Jnumed.119.228296  0.194
2019 Kramer K, Pandit-Taskar N, Donzelli M, Wolden SL, Zanzonico P, Humm J, Haque S, Souweidane MM, Lewis J, Lyashchenko SK, Larson SM, Cheung NV. Intraventricular radioimmunotherapy targeting B7H3 for CNS malignancies. Journal of Clinical Oncology. 37: e13592-e13592. DOI: 10.1200/Jco.2019.37.15_Suppl.E13592  0.194
1979 Russell JE, Kleerekoper M, Slatopolsky E, Lewis J, Lee SW, Avioli LV. Dissociation of renal cyclic AMP and phosphate responses to parathyroid hormone in uremia. Calcified Tissue International. 29: 147-154. PMID 228820 DOI: 10.1007/Bf02408070  0.194
2007 Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Lewis JS. Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 64-72. PMID 17204700  0.192
1965 Kasenally AS, Lewis J, Manning AR, Miller JR, Nyholm RS, Stiddard MHB. 618. Metal-metal bonds. Part II. Further complexes containing gold-manganese bonds Journal of the Chemical Society (Resumed). 3407-3411. DOI: 10.1039/Jr9650003407  0.191
1965 Lewis J, Miller JR, Richards RL, Thompson A. 1098. The infrared spectra of some addition compounds of aluminium and gallium trihalides Journal of the Chemical Society (Resumed). 5850-5860. DOI: 10.1039/Jr9650005850  0.191
1970 Johnson BFG, Lewis J, Robinson PW, Miller JR. Infrarotspektren Von Metallcarbonylverbindungen 3. Mitt. Austauschuntersuchungen An Tetracarbonylrhodiumkomplexen Des Typs Rh2X2(Co)4 (X=Cl, Br, J. Set Oder Sph) Cheminform. 1. DOI: 10.1002/Chin.197007118  0.188
1967 Johnson BFG, Lewis J, Miller JR, Robinson BH, Robinson PW, Wojcicki A. C18O exchange studies on Mn(CO)5X systems (X = Cl or Br) Chemical Communications (London). DOI: 10.1039/C1967000379A  0.185
2020 Chow A, Schad S, Green M, Hellmann M, Ceglia N, Allaj V, Zago G, Shah N, Sharma S, Mattar M, Chan J, Rizvi H, Zhong H, Liu C, Bykov Y, ... ... Lewis J, et al. 524 Tim-4+ resident macrophages impair anti-tumor immunity in the serous body cavities By sequestering viable and cytotoxic CD8+ T cells expressing high levels of phosphatidylserine Journal For Immunotherapy of Cancer. 8: A560-A560. DOI: 10.1136/jitc-2020-sitc2020.0524  0.184
2007 Abraham R, Malkani AL, Lewis J, Beck D. An anatomical study of tibial metaphyseal/diaphyseal mismatch during revision total knee arthroplasty. The Journal of Arthroplasty. 22: 241-4. PMID 17275641 DOI: 10.1016/J.Arth.2006.06.001  0.184
2020 Modak S, Zanzonico P, Grkovski M, Slotkin EK, Carrasquillo JA, Lyashchenko SK, Lewis JS, Cheung IY, Heaton T, LaQuaglia MP, Cheung NV, Pandit-Taskar N. B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001974. PMID 33119478 DOI: 10.1200/JCO.20.01974  0.184
1970 Johnson BFG, Lewis J, Robinson PW. Massenspektren Von Anorganischen Molekuelen 6. Mitt. Uebergangsmetall-Hydrid-Komplexe Cheminform. 1. DOI: 10.1002/Chin.197036106  0.182
1991 Gade LH, Johnson BFG, Lewis J, McPartlin M, Kotch T, Lees AJ. Photochemical core manipulation in high-nuclearity osmium-mercury clusters Journal of the American Chemical Society. 113: 8698-8704. DOI: 10.1021/Ja00023A017  0.182
2022 Tully KM, Tendler S, Carter LM, Sharma SK, Samuels ZV, Mandleywala K, Korsen JA, Delos Reyes AM, Piersigilli A, Travis WD, Sen T, Pillarsetty N, Poirier JT, Rudin CM, Lewis JS. Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer exhibits antitumor efficacy with low toxicity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35046060 DOI: 10.1158/1078-0432.CCR-21-1533  0.182
1970 Johnson BFG, Lewis J, Williams IG. Chemie Mehrkerniger Verbindungen 19. Mitt. Rk.-Produkte Von Dodecacarbonyltriruthenium Und Di-N-Butylaether Cheminform. 1. DOI: 10.1002/Chin.197027114  0.182
2003 Lewis JS, Connett J, Ye D, Dehdashti F, Grigsby P, Mintun MA, Laforest R, Welch MJ. Po-topic IV-01 Academic Radiology. 10: 953-954. DOI: 10.1016/S1076-6332(03)00037-0  0.182
2020 Weber WA, Czernin J, Anderson CJ, Badawi RD, Barthel H, Bengel F, Bodei L, Buvat I, DiCarli M, Graham MM, Grimm J, Herrmann K, Kostakoglu L, Lewis JS, Mankoff DA, et al. The Future of Nuclear Medicine, Molecular Imaging, and Theranostics. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 61: 263S-272S. PMID 33293447 DOI: 10.2967/jnumed.120.254532  0.181
2021 Carter LM, Ocampo Ramos JC, Bolch WE, Lewis JS, Kesner AL. Technical Note: Patient-morphed mesh-type phantoms to support personalized nuclear medicine dosimetry - a proof of concept study. Medical Physics. PMID 33595863 DOI: 10.1002/mp.14784  0.179
2015 Lewis JS. Precision Medicine…Visualized-a Message from the President of the WMIC. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 443-4. PMID 26041549 DOI: 10.1007/S11307-015-0867-Z  0.179
1970 Crooks GR, Johnson BFG, Lewis J, Williams IG, Gamlen G. Chemie Von Mehrkernigen Verbindungen 17. Mitt. Carboxylat-Komplexe Von Ruthenium- Und Osmiumcarbonylen Cheminform. 1. DOI: 10.1002/Chin.197008288  0.177
2014 Spratt D, Fareedy S, Lindgren S, Robinson B, Larson S, Lewis J, Bander N, Scherr D, Osborne J. Molecular Imaging for Localized Prostate Cancer: Analysis of 2 Prospective Phase 0 Trials of PSMA Targeted Immuno-PET and -SPECT, and Implications for the Radiation Oncologist International Journal of Radiation Oncology*Biology*Physics. 90: S208. DOI: 10.1016/J.Ijrobp.2014.05.770  0.177
2011 Lee J, Lewis J, DeWees T, Nussenbaum B, Adkins D, Haughey B, Thorstad W. IMRT for Oropharyngeal Carcinoma: Impact of Nodal Volume and HPV Status International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.797  0.176
2012 Thorstad WL, Spencer C, Adkins D, Nussenbaum B, Lewis J, Wildes T, Haughey B. Surgical Treatment Intensification for HPV-Negative Oropharyngeal Squamous Cell Carcinoma (OSCC) International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1236  0.175
2024 Ahad A, Saeed HK, Del Solar V, López-Hernández JE, Michel A, Mathew J, Lewis JS, Contel M. Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model". Acs Pharmacology & Translational Science. 7: 298-299. PMID 38230288 DOI: 10.1021/acsptsci.3c00364  0.173
1970 Johnson BFG, Lewis J, Robinson PW. Chemie Vielkerniger Verbindungen 20. Mitt. Reaktivitaet Von Hexadecacarbonylhexarhodium Cheminform. 1. DOI: 10.1002/Chin.197028093  0.171
2006 Wei L, Easmon J, Nagi RK, Muegge BD, Meyer LA, Lewis JS. 64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 2034-41. PMID 17138747  0.17
2023 Bakht MK, Yamada Y, Ku SY, Venkadakrishnan VB, Korsen JA, Kalidindi TM, Mizuno K, Ahn SH, Seo JH, Garcia MM, Khani F, Elemento O, Long HW, Chaglassian A, Pillarsetty N, ... Lewis JS, et al. Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. Nature Cancer. PMID 37038004 DOI: 10.1038/s43018-023-00539-6  0.169
2006 Paul R, Dearling J, Halsted P, Ballinger J, Lewis J, Martin K, McQuade P, Marsden P, O??Doherty M, Blower P. P47 Son of CuATSM: towards optimized second-generation copper complexes for hypoxia imaging Nuclear Medicine Communications. 27: 309. DOI: 10.1097/00006231-200603000-00129  0.165
2016 Sood N, Desai K, Chindris AM, Lewis J, Dinh TA. Symptomatic Ovarian Steroid Cell Tumor not Otherwise Specified in a Post-Menopausal Woman. Rare Tumors. 8: 6200. PMID 27441075 DOI: 10.4081/rt.2016.6200  0.165
2020 Pereira PMR, Mandleywala K, Ragupathi A, Lewis JS. Acute statin treatment improves antibody accumulation in EGFR- and PSMA-expressing tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32998959 DOI: 10.1158/1078-0432.CCR-20-1960  0.163
2023 Phipps MD, Cingoranelli S, Bhupathiraju NVSDK, Younes A, Cao M, Sanders VA, Neary MC, Devany MH, Cutler CS, Lopez GE, Saini S, Parker CC, Fernandez SR, Lewis JS, Lapi SE, et al. Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals. Inorganic Chemistry. PMID 36724083 DOI: 10.1021/acs.inorgchem.2c03931  0.162
2021 Ma MT, Lewis JS. State-of-the-Art of Radiometal-based Bioconjugates for Molecular Imaging and Radiotherapy. Bioconjugate Chemistry. 32: 1175-1176. PMID 34284590 DOI: 10.1021/acs.bioconjchem.1c00303  0.162
2002 Lewis JS, Herrero P, Sharp TL, Engelbach JA, Fujibayashi Y, Laforest R, Kovacs A, Gropler RJ, Welch MJ. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 1557-69. PMID 12411560  0.158
2021 Bolaender A, Zatorska D, He H, Joshi S, Sharma S, Digwal CS, Patel HJ, Sun W, Imber BS, Ochiana SO, Patel MR, Shrestha L, Shah SK, Wang S, Karimov R, ... ... Lewis JS, et al. Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system. Nature Communications. 12: 4669. PMID 34344873 DOI: 10.1038/s41467-021-24821-2  0.157
2023 Majeed U, Seegobin K, Lewis J, Li S, Zhao Y, Lou Y, Manochakian R. Lung Cancer in Patients With Lynch Syndrome: Association or Coincidence? Clinical Lung Cancer. PMID 37336713 DOI: 10.1016/j.cllc.2023.05.007  0.157
2020 Brito A, Pereira PMR, Soares da Costa D, Reis RL, Ulijn RV, Lewis JS, Pires RA, Pashkuleva I. Inhibiting cancer metabolism by aromatic carbohydrate amphiphiles that act as antagonists of the glucose transporter GLUT1. Chemical Science. 11: 3737-3744. PMID 34094062 DOI: 10.1039/d0sc00954g  0.152
2023 Pratt EC, Shaffer TM, Bauer D, Lewis JS, Grimm J. Radiances of Cerenkov-Emitting Isotopes on the IVIS. Biorxiv : the Preprint Server For Biology. PMID 36711894 DOI: 10.1101/2023.01.18.524625  0.151
2023 Maron SB, Chatila W, Walch H, Chou JF, Ceglia N, Ptashkin R, Do RKG, Paroder V, Pandit-Taskar N, Lewis JS, Biachi De Castria T, Sabwa S, Socolow F, Feder L, Thomas J, et al. Determinants of survival in HER2+ metastatic esophagogastric cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37406106 DOI: 10.1158/1078-0432.CCR-22-3769  0.132
1996 Lewis JS, Dearling JL, Zweit J, Carnochan P, Rooney BC, Blower PJ. 38. Synthesis and biological evaluation of cationic 64Cu-bis-(diphosphine) complexes Nuclear Medicine Communications. 17: 267. DOI: 10.1097/00006231-199604000-00040  0.131
2006 Welch MJ, Lewis JS, Kim J, Sharp TL, Dence CS, Gropler RJ, Herrero P. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 689-97. PMID 16595504  0.128
2012 Siddiqui AA, Sarkar A, Beltz S, Lewis J, Loren D, Kowalski T, Fang J, Hilden K, Adler DG. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointestinal Endoscopy. 76: 44-51. PMID 22726465 DOI: 10.1016/j.gie.2012.02.036  0.126
2007 Schoenemann PT, Gee J, Avants B, Holloway RL, Monge J, Lewis J. Validation of plaster endocast morphology through 3D CT image analysis. American Journal of Physical Anthropology. 132: 183-92. PMID 17103425 DOI: 10.1002/Ajpa.20499  0.109
2008 Liang XH, Lewis J, Foote R, Smith D, Kademani D. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 66: 1875-80. PMID 18718395 DOI: 10.1016/j.joms.2008.04.009  0.109
2012 Avila-Rodriguez MA, O'Neil JP, Barnhart TE, Dick DW, Koziorowski JM, Lapi SE, Lewis JS. Preface: 14th International Workshop on Targetry and Target Chemistry (WTTC) Aip Conference Proceedings. 1509: 1. DOI: 10.1063/1.4773929  0.099
2020 Huang RH, Sobol NB, Younes A, Mamun T, Lewis JS, Ulijn RV, O'Brien SP. Comparison of Methods for Surface Modification of Barium Titanate Nanoparticles for Aqueous Dispersibility: Towards Biomedical Utilization of Perovskite Oxides. Acs Applied Materials & Interfaces. PMID 32988209 DOI: 10.1021/acsami.0c10063  0.096
2022 Faghani S, Codipilly DC, Vogelsang D, Moassefi M, Rouzrokh P, Khosravi B, Agarwal S, Dhaliwal L, Katzka DA, Hagen C, Lewis J, Leggett CL, Erickson BJ, Iyer PG. Development of a Deep Learning Model for the Histological Diagnosis of Dysplasia in Barrett's Esophagus. Gastrointestinal Endoscopy. PMID 35718071 DOI: 10.1016/j.gie.2022.06.013  0.092
2023 Rana HS, Dertinger JE, Clabeaux C, Makepeace N, Lewis J. Metastatic Melanoma to the Orbit With Dedifferentiation: A Case Report. Cureus. 15: e41591. PMID 37559849 DOI: 10.7759/cureus.41591  0.092
2016 Moris M, Dawson DW, Jiang J, Lewis J, Nassar A, Takeuchi KK, Lay AR, Zhai Q, Donahue TR, Kelly KA, Crawford HC, Wallace M. Plectin-1 as a Biomarker of Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Multicenter Study. Pancreas. PMID 27101571 DOI: 10.1097/Mpa.0000000000000652  0.089
2017 Koop A, Brauhmbhatt B, Lewis J, Lewis MD. Gastrointestinal Bleeding from Metastatic Prostate Adenocarcinoma to the Stomach. Acg Case Reports Journal. 4: e47. PMID 28377935 DOI: 10.14309/crj.2017.47  0.083
2006 Herrero P, Kim J, Sharp TL, Engelbach JA, Lewis JS, Gropler RJ, Welch MJ. Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 477-85. PMID 16513617  0.079
1997 Blower PJ, Lewis JS, Dearling JL, Rooney BC, Kelland L, Coley H, Zweit J. 34. Copper diphosphine complexes Nuclear Medicine Communications. 18: 298. DOI: 10.1097/00006231-199704000-00036  0.078
2023 Codipilly DC, Faghani S, Hagan C, Lewis J, Erickson BJ, Iyer PG. The Evolving Role of Artificial Intelligence in Gastrointestinal Histopathology: An Update. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 38154727 DOI: 10.1016/j.cgh.2023.11.044  0.077
2024 Nawaz N, Mistretta T, Karime C, Lewis J, Wolf E. Cholestatic Drug-Induced Liver Injury in a Patient Taking High-Dose Niacin for Hyperlipidemia. Journal of Investigative Medicine High Impact Case Reports. 12: 23247096231224349. PMID 38193433 DOI: 10.1177/23247096231224349  0.064
2020 Lewis J, Dhami J, Langue M, Smink G. Traumatic Hyphema in a Type 1 Von Willebrand Patient: Clinical Case and Management Blood. 136: 30-30. DOI: 10.1182/blood-2020-140435  0.061
2001 Lewis JS, Taylor JF, Miklos AZ, Virgo KS, Creer MH, Ritter DG. Clinical significance of low-positive troponin I by AxSYM and ACS:180. American Journal of Clinical Pathology. 116: 396-402. PMID 11554168 DOI: 10.1309/EHMY-7WU1-UYE7-EE99  0.06
2020 Baimas-George M, Passeri MJ, Lyman WB, Dries A, Narang T, Deal S, Lewis J, Chauhan S, Martinie J, Vrochides D, Baker E, Iannitti D. A Single-Center Experience with Minimally Invasive Transgastric ERCP in Patients with Previous Gastric Bypass: Lessons Learned and Technical Considerations. The American Surgeon. 86: 300-307. PMID 32391753  0.059
2020 Baimas-George M, Passeri MJ, Lyman WB, Dries A, Narang T, Deal S, Lewis J, Chauhan S, Martinie J, Vrochides D, Baker E, Iannitti D. A Single-Center Experience with Minimally Invasive Transgastric ERCP in Patients with Previous Gastric Bypass: Lessons Learned and Technical Considerations The American Surgeon. 86: 300-307. DOI: 10.1177/000313482008600425  0.059
2017 Libertin CR, Reza M, Peterson JH, Lewis J, Hata DJ. Human Gongylonema pulchrum Infection: Esophageal Symptoms and Need for Prolonged Albendazole Therapy. The American Journal of Tropical Medicine and Hygiene. PMID 28138043 DOI: 10.4269/ajtmh.16-0852  0.059
2010 Reichert DE, Lewis JS, Anderson CJ. ChemInform Abstract: Metal Complexes as Diagnostic Tools Cheminform. 30: no-no. DOI: 10.1002/chin.199930273  0.058
2017 Dubosh NM, Fisher J, Lewis J, Ullman EA. Faculty Evaluations Correlate Poorly with Medical Student Examination Performance in a Fourth-Year Emergency Medicine Clerkship. The Journal of Emergency Medicine. PMID 28341085 DOI: 10.1016/j.jemermed.2016.09.018  0.057
2007 Kademani D, Baltali E, Baltlai E, Lewis J, Keller E. Analysis of death certification in patients with early stage oral cavity squamous cell carcinoma. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 65: 1191-7. PMID 17517305 DOI: 10.1016/J.JOMS.2006.09.009  0.052
2005 Lewis J, Specks U, Jacob G, Homburger H. Subtle modifications of a PR3-ANCA ELISA affect assay performance. Clinical Immunology (Orlando, Fla.). 118: 124-5. PMID 16209936 DOI: 10.1016/j.clim.2005.08.011  0.052
2014 Adamcewicz M, Chen K, Lewis J, Marino D, Shah A. Extensive Cerebral Sinus Venous Thrombosis in a Crohn’s Patient on Adalimumab Therapy Presenting as Severe Headache and Vision Change American Journal of Gastroenterology. 109: S443. DOI: 10.14309/00000434-201410002-01505  0.05
2016 Winn CO, Ford PR, McNarry MA, Lewis J, Stratton G. The effect of deprivation on the developmental activities of adolescent rugby union players in Wales. Journal of Sports Sciences. 1-7. PMID 28019721 DOI: 10.1080/02640414.2016.1271136  0.05
2011 Azarbal A, Rowell S, Lewis J, Urankar R, Moseley S, Landry G, Moneta G. Duplex ultrasound screening detects high rates of deep vein thromboses in critically ill trauma patients Journal of Vascular Surgery. 54: 743-748. PMID 21620614 DOI: 10.1016/j.jvs.2011.02.058  0.05
1989 Roongpisuthipong A, Lewis JS, Kraus SJ, Morse SA. Gonococcal urethritis diagnosed from enzyme immunoassay of urine sediment. Sexually Transmitted Diseases. 15: 192-5. PMID 3147523 DOI: 10.1097/00007435-198810000-00003  0.049
2014 Lewis J, Abdalla M, Ren B, Granato C, Evans A, Ramaraju G, Shah A. Burkitt Lymphoma Complicating Azathioprine Therapy in Ulcerative Colitis Patient With Autoimmune Hepatitis Syndrome/Primary Sclerosing Cholangitis Overlap Syndrome American Journal of Gastroenterology. 109: S442. DOI: 10.14309/00000434-201410002-01498  0.047
2019 Lewis J, Ellington A. Practicing Instrumental Activities of Daily Living With Virtual Reality (VR): Patient Perceptions of SaeboVR in the Home and Clinician Feedback on SaeboVR American Journal of Occupational Therapy. 73: 7311505160p1. DOI: 10.5014/ajot.2019.73s1-po6009  0.044
2022 Lipson M, Sawchuk EA, Thompson JC, Oppenheimer J, Tryon CA, Ranhorn KL, de Luna KM, Sirak KA, Olalde I, Ambrose SH, Arthur JW, Arthur KJW, Ayodo G, Bertacchi A, Cerezo-Román JI, ... ... Lewis J, et al. Ancient DNA and deep population structure in sub-Saharan African foragers. Nature. PMID 35197631 DOI: 10.1038/s41586-022-04430-9  0.042
2023 Loeb L, Lewis J, Peng Z, Heckman MG, Nakhleh R, Keaveny AP. A clinical review of congenital hepatic fibrosis diagnosed in adulthood: presentation, complications, and outcomes. Annals of Hepatology. 29: 101164. PMID 37802414 DOI: 10.1016/j.aohep.2023.101164  0.041
2021 Kurtzman N, Adler J, Ketterer A, Lewis J. Rare Complications of Acute Appendicitis: A Case Report. Clinical Practice and Cases in Emergency Medicine. 5: 66-69. PMID 33560955 DOI: 10.5811/cpcem.2020.11.49601  0.041
2021 Kanjee Z, Beltran CP, Smith CC, Lewis J, Hall MM, Tibbles CD, Sullivan AM. "Friction by Definition": Conflict at Patient Handover Between Emergency and Internal Medicine Physicians at an Academic Medical Center. The Western Journal of Emergency Medicine. 22: 1227-1239. PMID 34787545 DOI: 10.5811/westjem.2021.7.52762  0.038
2023 Boës X, Van Bocxlaer B, Prat S, Feibel C, Lewis J, Arrighi V, Taylor N, Harmand S. Aridity, availability of drinking water and freshwater foods, and hominin and archeological sites during the Late Pliocene-Early Pleistocene in the western region of the Turkana Basin (Kenya): A review. Journal of Human Evolution. 186: 103466. PMID 38134581 DOI: 10.1016/j.jhevol.2023.103466  0.038
2017 Lewis J, Dubosh N, Rosen C, Schoenfeld D, Fisher J, Ullman E. Interview Day Environment May Influence Applicant Selection of Emergency Medicine Residency Programs. The Western Journal of Emergency Medicine. 18: 142-145. PMID 28116027 DOI: 10.5811/westjem.2016.10.31245  0.035
Hide low-probability matches.